
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs2.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500003774BDBFB94A.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="pnas" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10589645/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589645/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Proceedings of the National Academy of Sciences of the United States of America" /><meta name="citation_title" content="A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis" /><meta name="citation_author" content="Cecilia Ka Wing Chan" /><meta name="citation_author_institution" content="aDepartment of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Cheuk Chun Szeto" /><meta name="citation_author_institution" content="bDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Leo Kit Cheung Lee" /><meta name="citation_author_institution" content="cDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Yu Xiao" /><meta name="citation_author_institution" content="cDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Bohan Yin" /><meta name="citation_author_institution" content="cDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Xiaofan Ding" /><meta name="citation_author_institution" content="aDepartment of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Thomas Wai Yip Lee" /><meta name="citation_author_institution" content="dSchool of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="James Yun Wong Lau" /><meta name="citation_author_institution" content="aDepartment of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_author" content="Chung Hang Jonathan Choi" /><meta name="citation_author_institution" content="cDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong" /><meta name="citation_publication_date" content="2023/10/10" /><meta name="citation_issue" content="42" /><meta name="citation_volume" content="120" /><meta name="citation_doi" content="10.1073/pnas.2305662120" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10589645/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10589645/" /><meta name="citation_pmid" content="37812696" /><meta name="DC.Title" content="A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Academy of Sciences" /><meta name="DC.Contributor" content="Cecilia Ka Wing Chan" /><meta name="DC.Contributor" content="Cheuk Chun Szeto" /><meta name="DC.Contributor" content="Leo Kit Cheung Lee" /><meta name="DC.Contributor" content="Yu Xiao" /><meta name="DC.Contributor" content="Bohan Yin" /><meta name="DC.Contributor" content="Xiaofan Ding" /><meta name="DC.Contributor" content="Thomas Wai Yip Lee" /><meta name="DC.Contributor" content="James Yun Wong Lau" /><meta name="DC.Contributor" content="Chung Hang Jonathan Choi" /><meta name="DC.Date" content="2023 Oct 17" /><meta name="DC.Identifier" content="10.1073/pnas.2305662120" /><meta name="DC.Language" content="en" /><meta property="og:title" content="A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis" /><meta property="og:type" content="article" /><meta property="og:description" content="Chronic kidney disease (CKD) affects ~10% of adults worldwide. Prolonged renal fibrosis leads to CKD and ultimately kidney failure that requires dialysis or transplantation. Current drugs can retard disease progression, but there are no specific treatments ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589645/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10589645/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2/">Proc Natl Acad Sci U S A</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/447702/">v.120(42); 2023 Oct 17</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10589645
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10589645/pdf/pnas.202305662.pdf" class="int-view">PDF (27M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10589645/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10589645/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10589645" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10589645%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="oLdw2BBbC92e3kvJvOoHjoDw9x7tDPA3WSJQ3xdNdpSLaVGKteGc8SJUxEyU85NW">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10589645%2F&amp;text=A%20sub-10-nm%2C%20folic%20acid-conjugated%20gold%20nanoparticle%20as%20self-therapeutic%20treatment%20of%20tubulointerstitial%20fibrosis%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10589645%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589645/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10589645/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37812696/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10589645/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37812696/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10589645/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10589645/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2/">Proc Natl Acad Sci U S A</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/447702/">v.120(42); 2023 Oct 17</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10589645
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><a href="//doi.org/10.1073%2Fpnas.2305662120" title="Link to Publisher's site" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"><img src="/corehtml/pmc/pmcgifs/logo-pnas.png" alt="Logo of pnas"><!-- --></img></a></div>
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Proc Natl Acad Sci U S A.</span> 2023 Oct 17; 120(42): e2305662120. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Oct 9. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1073%2Fpnas.2305662120" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1073/pnas.2305662120</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10589645</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37812696">37812696</a></div></div></div><h1 class="content-title">A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chan%20CK%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455699275424" co-class="co-affbox">Cecilia Ka Wing Chan</a>,<sup>
a
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Szeto%20CC%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455659045728" co-class="co-affbox">Cheuk Chun Szeto</a>,<sup>
b
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20LK%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455700268896" co-class="co-affbox">Leo Kit Cheung Lee</a>,<sup>
c
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xiao%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455700265904" co-class="co-affbox">Yu Xiao</a>,<sup>
c
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yin%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455700262800" co-class="co-affbox">Bohan Yin</a>,<sup>
c
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ding%20X%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455700260432" co-class="co-affbox">Xiaofan Ding</a>,<sup>
a
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20TW%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455700258064" co-class="co-affbox">Thomas Wai Yip Lee</a>,<sup>
d
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lau%20JY%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455700255696" co-class="co-affbox">James Yun Wong Lau</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
a
,</sup><sup>
1
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Choi%20CH%5BAuthor%5D" class="affpopup" co-rid="_co_idm140455664008704" co-class="co-affbox">Chung Hang Jonathan Choi</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
c
,</sup><sup>
1
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140455699275424"><h3 class="no_margin">Cecilia Ka Wing Chan</h3><p><sup>a</sup>Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chan%20CK%5BAuthor%5D">Cecilia Ka Wing Chan</a></div></div><div id="_co_idm140455659045728"><h3 class="no_margin">Cheuk Chun Szeto</h3><p><sup>b</sup>Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Szeto%20CC%5BAuthor%5D">Cheuk Chun Szeto</a></div></div><div id="_co_idm140455700268896"><h3 class="no_margin">Leo Kit Cheung Lee</h3><p><sup>c</sup>Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20LK%5BAuthor%5D">Leo Kit Cheung Lee</a></div></div><div id="_co_idm140455700265904"><h3 class="no_margin">Yu Xiao</h3><p><sup>c</sup>Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xiao%20Y%5BAuthor%5D">Yu Xiao</a></div></div><div id="_co_idm140455700262800"><h3 class="no_margin">Bohan Yin</h3><p><sup>c</sup>Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yin%20B%5BAuthor%5D">Bohan Yin</a></div></div><div id="_co_idm140455700260432"><h3 class="no_margin">Xiaofan Ding</h3><p><sup>a</sup>Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ding%20X%5BAuthor%5D">Xiaofan Ding</a></div></div><div id="_co_idm140455700258064"><h3 class="no_margin">Thomas Wai Yip Lee</h3><p><sup>d</sup>School of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20TW%5BAuthor%5D">Thomas Wai Yip Lee</a></div></div><div id="_co_idm140455700255696"><h3 class="no_margin">James Yun Wong Lau</h3><p><sup>a</sup>Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lau%20JY%5BAuthor%5D">James Yun Wong Lau</a></div></div><div id="_co_idm140455664008704"><h3 class="no_margin">Chung Hang Jonathan Choi</h3><p><sup>c</sup>Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Choi%20CH%5BAuthor%5D">Chung Hang Jonathan Choi</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140455662388432_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140455662388432_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140455662388432_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140455662388432_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>a</sup>Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</div><div class="fm-affl" id="aff2"><sup>b</sup>Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</div><div class="fm-affl" id="aff3"><sup>c</sup>Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</div><div class="fm-affl" id="aff4"><sup>d</sup>School of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><span class="contrib-email" id="contrib-a.j.b.f.h">James Yun Wong Lau: <a href="mailto:dev@null" data-email="kh.ude.khuc.yregrus@wyjual" class="oemail">kh.ude.khuc.yregrus@wyjual</a>; </span> <span class="contrib-email" id="contrib-a.j.b.f.i">Chung Hang Jonathan Choi: <a href="mailto:dev@null" data-email="kh.ude.khuc@iohchcj" class="oemail">kh.ude.khuc@iohchcj</a></span> </div><div id="cor1"><sup>1</sup>To whom correspondence may be addressed. Email: <a href="mailto:dev@null" data-email="kh.ude.khuc.yregrus@wyjual" class="oemail">kh.ude.khuc.yregrus@wyjual</a> or <a href="mailto:dev@null" data-email="kh.ude.khuc@iohchcj" class="oemail">kh.ude.khuc@iohchcj</a>.</div><div id="fn1">Edited by Catherine Murphy, University of Illinois at Urbana-Champaign, Urbana, IL; received April 14, 2023; accepted September 11, 2023</div></div><div class="fm-article-notes hide half_rhythm" id="idm140455662388432_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Apr 14; Accepted 2023 Sep 11.</div></div><div class="permissions half_rhythm hide" id="idm140455662388432_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2023 the Author(s). Published by PNAS.</div><div class="license half_rhythm">This open access article is distributed under <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License 4.0 (CC BY)</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Appendix 01 (PDF)</div><div><a href="/pmc/articles/PMC10589645/bin/pnas.2305662120.sapp.pdf" data-ga-action="click_feat_suppl">pnas.2305662120.sapp.pdf</a><span style="color:gray"> (6.1M)</span></div><div class="small guid">GUID: 393574E3-7C51-442E-8C5C-44D3AB59BE1C</div></div></dd></dl><dl data-length="62" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">All study data are included in the article and/or <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em></a>.</p></dd></dl></div><div id="abstract-a.j.b.q" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.j.b.qtitle" style="text-transform: uppercase;">Significance</h2><!--article-meta--><div><p class="p p-first-last">Chronic kidney disease (CKD) affects ~10% of adults worldwide. Prolonged renal fibrosis leads to CKD and ultimately kidney failure that requires dialysis or transplantation. Current drugs can retard disease progression, but there are no specific treatments for tubulointerstitial fibrosis, a common manifestation of end-stage CKD. Nanomedicines hold immense potential for treating CKD, but their delivery to renal tubules is challenging, and many past examples were preventive. Leveraging the overexpression of folate receptors on selected tubule cells in the fibrotic kidney, this sub-10-nm folic acid&#x02013;conjugated gold nanoparticle can selectively accumulate in the fibrotic kidney, enter tubules, inhibit CKD-related kinases, and treat tubulointerstitial fibrosis after disease establishment. Consideration of pathophysiology and adoption of self-therapeutic nanoparticles will jointly inspire effective treatments.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">nanomedicine, gold nanoparticle, chronic kidney disease, fibrosis, renal tubules</span></div></div><div id="abstract-a.j.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.j.b.rtitle" style="text-transform: uppercase;">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Nanomedicines for treating chronic kidney disease (CKD) are on the horizon, yet their delivery to renal tubules where tubulointerstitial fibrosis occurs remains inefficient. We report a folic acid-conjugated gold nanoparticle that can transport into renal tubules and treat tubulointerstitial fibrosis in mice with unilateral ureteral obstruction. The 3-nm gold core allows for the dissection of bio&#x02013;nano interactions in the fibrotic kidney, ensures the overall nanoparticle (~7 nm) to be small enough for glomerular filtration, and naturally inhibits the p38&#x003b1; mitogen-activated protein kinase in the absence of chemical or biological drugs. The folic acids support binding to selected tubule cells with overexpression of folate receptors and promote retention in the fibrotic kidney. Upon intravenous injection, this nanoparticle can selectively accumulate in the fibrotic kidney over the nonfibrotic contralateral kidney at ~3.6% of the injected dose. Delivery to the fibrotic kidney depends on nanoparticle size and disease stage. Notably, a single injection of this self-therapeutic nanoparticle reduces tissue degeneration, inhibits genes related to the extracellular matrix, and treats fibrosis more effectively than standard Captopril therapy. Our data underscore the importance of constructing CKD nanomedicines based on renal pathophysiology.</p></div></div><div id="body-a.k" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">Renal fibrosis represents a failed wound-healing process in the kidney after sustained injury. Left untreated, it can lead to chronic kidney disease (CKD) and ultimately kidney failure (<a href="#r1" rid="r1" class=" bibr popnode">1</a>). Renal fibrosis is characterized by excessive accumulation of extracellular matrix (ECM), infiltration of inflammatory cells, and a loss of kidney tissue. Developing treatments for renal fibrosis is an unmet clinical need as there is no specific treatment. Immunosuppressive (<a href="#r2" rid="r2" class=" bibr popnode">2</a>) and blood pressure control drugs (<a href="#r3" rid="r3" class=" bibr popnode">3</a>) can only retard the progression of renal fibrosis, but their side effects include hypotension and hyperkalemia.</p><p>Nanoparticles (NPs) are promising drug carriers to the kidneys because their delivery is tailorable by adjusting NP physicochemical properties (<a href="#r4" rid="r4" class=" bibr popnode">4</a>, <a href="#r5" rid="r5" class=" bibr popnode">5</a>). However, past reports on using NPs for alleviating renal fibrosis were relatively uncommon (with merely ~20 reports to date; <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S1 and Table S1</a>), partly due to their inefficient delivery to renal tubules (<a href="#r6" rid="r6" class=" bibr popnode">6</a>), the major site of tubulointerstitial fibrosis (<a href="#r7" rid="r7" class=" bibr popnode">7</a>). Of all CKD etiologies, tubulointerstitial fibrosis is a common histological manifestation of late-stage CKD and a strong predictor of disease progression (<a href="#r8" rid="r8" class=" bibr popnode">8</a>). Past researchers employed large NPs (&#x02265;100 nm in diameter) loaded with siRNA (<a href="#r9" rid="r9" class=" bibr popnode">9</a>) and small molecules (<a href="#r10" rid="r10" class=" bibr popnode">10</a>) for passive delivery or folic acid (FA)-containing NPs to bind to folate receptors (FRs) on the apical membrane of tubular cells to achieve retention in the kidney (<a href="#r11" rid="r11" class=" bibr popnode">11</a>), but these NPs need to disassemble unpredictably in the bloodstream to cross the glomerular filtration barrier [GFB; with a typical cutoff size of &#x0003c;10 nm (<a href="#r12" rid="r12" class=" bibr popnode">12</a>)] before reaching the renal tubules. Conversely, ultrasmall NPs (&#x02264;5 nm) can efficiently penetrate the GFB upon intravenous (i.v.) injection in healthy animals (<a href="#r13" rid="r13" class=" bibr popnode">13</a>) and models with renal fibrosis (<a href="#r14" rid="r14" class=" bibr popnode">14</a>), but they were used only as in vivo contrast agents intended for fast urine clearance instead of as therapeutics where retention in the kidney is critical (<a href="#r15" rid="r15" class=" bibr popnode">15</a>). Summing up, an NP large enough to contain antifibrotic drugs and tubule-targeting ligands while small enough to penetrate the GFB for accessing renal tubules remains elusive.</p><p class="p">We report ~7-nm FA-conjugated gold NPs for bypassing the delivery hurdle to renal tubules and treating tubulointerstitial fibrosis. The 3-nm gold core serves three functions, namely i) supporting the dissection of the bio&#x02013;nano interactions of NPs with the fibrotic kidney, ii) keeping the overall NP &#x0003c;10 nm to balance both GFB passage and kidney retention, and iii) surprisingly, acting as a self-therapeutic agent for inhibiting p38&#x003b1; mitogen-activated protein kinase (MAPK) without using chemical or biological drugs. Activation of p38&#x003b1; plays a vital role in renal fibrosis and acts downstream of transforming growth factor-&#x003b2;, a mediator of ECM deposition (<a href="#r16" rid="r16" class=" bibr popnode">16</a>), therefore inhibition of p38&#x003b1; represents a suitable strategy for the pharmacological intervention of renal fibrosis. The conjugated FA molecules empower binding to FRs on renal tubules. We identify the localized upregulation of FRs on some tubules of the fibrotic kidney in CKD patients and in mice with unilateral ureteral obstruction (UUO) (<a href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Fig. 1<em>A</em></span></a>), an established animal model for tubulointerstitial fibrosis (<a href="#r17" rid="r17" class=" bibr popnode">17</a>). Upon i.v. injection into UUO mice, this FA-conjugated gold NP accumulates preferentially in the fibrotic kidney (3.6% of injected dose; %ID) over the nonfibrotic contralateral (CL) kidney (0.6% ID). After disease establishment, a single injection of the NP reduces tissue degeneration, down-regulates genes linked to collagen-related ECM, and treats fibrosis more effectively than Captopril, a standard blood pressure control drug for alleviating CKD (<a href="#r18" rid="r18" class=" bibr popnode">18</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig01" co-legend-rid="lgnd_fig01"><a href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140455657652928"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10589645_pnas.2305662120fig01.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pnas.2305662120fig01.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10589645/bin/pnas.2305662120fig01.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140455657652928"><a target="object" rel="noopener" href="/pmc/articles/PMC10589645/figure/fig01/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig01"><div><a class="figpopup" href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01">Fig. 1.</a></div><!--caption a7--><div class="caption"><p>Passive delivery of Au<sub>x</sub>-PEG<sub>y</sub> NPs to the fibrotic kidney. (<em>A</em>) UUO in mice is obtained by ligating the left ureter twice with sutures. (<em>B</em>) Distribution of Au<sub>x</sub>-PEG<sub>y</sub> NPs in the UUO kidney and contralateral (CL) kidney 24 h postinjection into mice on day 7 post-UUO surgery. %ID = percentage of injected dose. Data are from n = 5 to 6, across one experiment. Statistical significance was evaluated using One-Way ANOVA with Tukey&#x02019;s post hoc test for multiple comparison. All <em>P</em> values &#x02264; 0.05 are displayed on the graph. All bars and error bars represent mean &#x000b1; SD. (<em>C</em>) Schematic illustration of kidney anatomy. Each nephron contains two functional subunits, namely glomerulus and the tubular system. The left <em>Inset</em> shows the flow of systemically injected NPs in the blood vessels that surround kidney tubules (or peritubular capillaries) and the right <em>Inset</em> shows the flow of NPs in the lumen of a renal tubule. (<em>D</em>) Silver enhancement staining of UUO kidney tissues showed that smaller Au<sub>2</sub>-PEG<sub>200</sub> and Au<sub>3</sub>-PEG<sub>500</sub> NPs could be found in the tubule lumen (red arrow), but larger Au<sub>5</sub>-PEG<sub>1000</sub>, Au<sub>5</sub>-PEG<sub>5000</sub>, and Au<sub>20</sub>-PEG<sub>5000</sub> NPs localized in peritubular capillaries (green arrow). Yellow or black dots: Au<sub>2</sub> NPs; black dots: AuNPs of larger sizes. The negative control histological image of the fibrotic kidney from uninjected mice shows the lack of detectable silver signals. Representative images from three kidney sections from each mouse, n = 3 mice/group. Representative locations of the renal tubule and tubule lumen were annotated as &#x0201c;t&#x0201d; and &#x0201c;l&#x0201d;, respectively. (<em>E</em>) Distribution of Au<sub>3</sub>-PEG<sub>500</sub> NPs to the UUO and CL kidneys 24 h postinjection as a function of disease stage. Data are presented in terms of %ID/ g of kidney tissue. Data are from n = 3, across one experiment.</p></div></div></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title" style="text-transform: uppercase;">Results and Discussion</h2><div id="s2" class="sec sec-first"><p></p><h3 id="s2title" class="inline">Effects of Disease Stage and NP Size on Passive Delivery to the Fibrotic Kidney. </h3><p class="p p-first">Although UUO is a primary model of interstitial fibrosis, past evidence suggests that glomerular permeability is also affected (<a href="#r19" rid="r19" class=" bibr popnode">19</a>, <a href="#r20" rid="r20" class=" bibr popnode">20</a>), potentially affecting the glomerular passage of NPs. Tubulointerstitial fibrosis irrespective to the initial cause affects glomerular hemodynamics and permeability, presumably via tubuloglomerular feedback. Therefore, it is imperative that the optimal NP size and disease stage be determined for delivery to the tubules of the fibrotic kidney. We prepared polyethylene glycol (PEG)-coated gold NPs (Au<sub>x</sub>-PEG<sub>y</sub> NPs) by reacting gold cores of different diameters (x in nm; <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S2</a>) with thiolated PEG strands of various molecular weights (y in Da). For NP characterization, we negatively stained the NPs for transmission electron microscopy (TEM) imaging and observed that their overall physical diameters (gold core plus outer PEG shell; <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S3 and S4</a>) are similar to their hydrodynamic sizes as measured by dynamic light scattering. The only exception was Au<sub>2</sub>-PEG<sub>200</sub> NP, its PEG shell did not have enough contrast to be imaged. (Typically, the TEM imaging contrast of sub-10-nm NPs was lower than that of the larger NPs probably because of its smaller Au core sizes and shorter PEG chain length.) This result indicates a dense coverage of PEG strands on the gold NP, consistent with literature precedent (<a href="#r21" rid="r21" class=" bibr popnode">21</a>). We verified that the PEG coverage density is &#x02265;2 PEG strands per nm<sup>2</sup> of gold surface using three methods, namely direct displacement of thiolated PEG strands from Au<sub>x</sub>-PEG<sub>y</sub> NP via dithiothreitol-induced aggregation of gold NPs (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Table S2</a>) (<a href="#r22" rid="r22" class=" bibr popnode">22</a>), indirect measurement of excess thiolated PEG strands unattached to the gold core during synthesis of Au<sub>x</sub>-PEG<sub>y</sub> NP (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Table S3<em>A</em></a>) (<a href="#r23" rid="r23" class=" bibr popnode">23</a>), and direct measurement of the organic content of Au<sub>x</sub>-PEG<sub>y</sub> NPs using thermogravimetric analysis (TGA; <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Table S3<em>B</em> and <em>SI Appendix</em>, Fig. S5</a>) (<a href="#r24" rid="r24" class=" bibr popnode">24</a>). All NPs were colloidally stable in 50% fetal bovine serum (FBS) for 24 h (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S6 and S7 and Table S4</a>) and were not cytotoxic to primary renal tubule cells isolated from healthy Balb/c mice (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S8</a>).</p><p>Initially, we explored the effect of NP size on delivery to the kidney by injecting Au<sub>x</sub>-PEG<sub>y</sub> NPs into UUO mice on day 7 post-UUO surgery and killed the animals 24 h postinjection. For all NP sizes, our chosen dose was a constant mass of 100 &#x000b5;g Au (or 10<sup>12</sup> to 10<sup>14</sup> NPs depending on NP size) per mouse, high enough to overcome any variation in organ retention due to NP dose (<a href="#r25" rid="r25" class=" bibr popnode">25</a>). Seven days is the minimal time required for renal fibrosis to be established (<a href="#r26" rid="r26" class=" bibr popnode">26</a>). By quantifying the gold contents in the kidneys by inductively coupled plasma&#x02013;mass spectrometry (ICP-MS), we detected at the organ level that the smallest Au<sub>2</sub>-PEG<sub>200</sub> NP accumulated most abundantly in both fibrotic UUO (1.8 %ID) and nonfibrotic contralateral (CL) (2.8 %ID) kidneys of the five NP sizes studied (<a href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Fig. 1<em>B</em></span></a> and <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S9</a>). The accumulation of Au<sub>3</sub>-PEG<sub>500</sub>, Au<sub>5</sub>-PEG<sub>1000</sub>, Au<sub>5</sub>-PEG<sub>5000</sub>, and Au<sub>20</sub>-PEG<sub>5000</sub> NPs in the UUO kidneys was similar (~1 %ID). At the tissue level, silver enhancement staining of the UUO kidney sections reveals that the smaller Au<sub>2</sub>-PEG<sub>200</sub> and Au<sub>3</sub>-PEG<sub>500</sub> NPs (&#x0003c;10 nm) could be found in the tubule lumen, but the larger Au<sub>5</sub>-PEG<sub>1000</sub>, Au<sub>5</sub>-PEG<sub>5000</sub>, and Au<sub>20</sub>-PEG<sub>5000</sub> NPs (&#x0003e;10 nm) were only localized in peritubular capillaries (<a href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Fig. 1 <em>C</em> and <em>D</em></span></a>). Kidney tissues of uninjected mice had no silver stain. These data suggest that Au<sub>2</sub>-PEG<sub>200</sub> and Au<sub>3</sub>-PEG<sub>500</sub> NPs have viable sizes to reach renal tubules. While Au<sub>2</sub>-PEG<sub>200</sub> NP more abundantly accumulates in the UUO kidney and are renally cleared more efficiently than Au<sub>3</sub>-PEG<sub>500</sub> NP (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S10</a>), we excluded Au<sub>2</sub>-PEG<sub>200</sub> NP from further investigations because it does not solubilize FA in water (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S11</a>). FA is poorly soluble in water under neutral conditions (<a href="#r27" rid="r27" class=" bibr popnode">27</a>), and PEG<sub>200</sub> is too short to solubilize FA (441 Da). Also, while the larger Au<sub>5</sub>-PEG<sub>5000</sub> NP accumulated slightly more in the UUO kidney than Au<sub>3</sub>-PEG<sub>500</sub> NP, it did not reach the renal tubules. Therefore, we concluded that Au<sub>3</sub>-PEG<sub>500</sub> NP has the optimal size for loading FA and delivery to renal tubules. Subsequently, we only kept Au<sub>3</sub>-PEG<sub>500</sub> NP (and its FA-conjugated version) to address their binding to FRs and delivery to tubules (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Figs. 2</span></a> and <a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and3),</span></span><span>3</span></a>), inhibition of renal fibrosis (<a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig04" rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span>Figs. 4</span></a> and <a href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig05" rid-ob="ob-fig05" co-legend-rid="lgnd_fig05"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and5),</span></span><span>5</span></a>), and inhibition of fibrosis-related genes and kinases (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig02" co-legend-rid="lgnd_fig02"><a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" rid-figpopup="fig02" rid-ob="ob-fig02"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140455664524992"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10589645_pnas.2305662120fig02.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pnas.2305662120fig02.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10589645/bin/pnas.2305662120fig02.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140455664524992"><a target="object" rel="noopener" href="/pmc/articles/PMC10589645/figure/fig02/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig02"><div><a class="figpopup" href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" rid-figpopup="fig02" rid-ob="ob-fig02">Fig. 2.</a></div><!--caption a7--><div class="caption"><p>In vitro and ex vivo binding of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs to folate receptor (FR) on renal tubules after 2 h postincubation of cells or tissue blocks with NPs. (<em>A</em>) IHC staining of kidney biopsies from patients with renal fibrosis showed that some fibrotic tubules have higher expression of FR (brown) than adjacent healthy tissues. Representative images from two kidney sections from each tissue group (healthy adjacent vs. fibrotic tubules vs. fibrotic scar). (<em>B</em>) In mice, IHC staining showed that the elevated expression of FR (brown) in selected tubule cells in the UUO kidney is distinct from the diffuse, homogenous FR expression in healthy and CL kidneys. Representative images from three kidney sections from each mouse, n = 3 mice/group. (<em>C</em>) Schematic of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP binding to FRs on the lumen side of a tubule cell. (<em>D</em>) Representative confocal images show stronger in vitro association of Cy5.5-labeled Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP (red; with white arrows) to FR (green) on healthy mouse primary renal tubule cells than Au<sub>3</sub>-PEG<sub>500</sub> NP. r: Pearson&#x02019;s colocalization coefficient. (<em>E</em>) Ex vivo association of Au<sub>3</sub>-PEG<sub>500</sub> and Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs to freshly diced UUO kidney blocks. Statistical significance was evaluated using the Mann&#x02013;Whitney <em>U</em> test. Error bar denotes 1 SD, with n = 3 across one experiment. (<em>F</em>) Ex vivo competitive binding assay. Diced UUO kidney blocks were incubated with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP with or without antibody against FR or megalin. Statistical significance was evaluated using one-way ANOVA with Tukey&#x02019;s post hoc test for multiple comparison. All <em>P</em> values &#x02264; 0.05 are displayed on the graphs. All bars and error bars represent mean &#x000b1; SD.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig03" co-legend-rid="lgnd_fig03"><a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" rid-figpopup="fig03" rid-ob="ob-fig03"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140455662985680"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10589645_pnas.2305662120fig03.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pnas.2305662120fig03.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10589645/bin/pnas.2305662120fig03.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140455662985680"><a target="object" rel="noopener" href="/pmc/articles/PMC10589645/figure/fig03/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig03"><div><a class="figpopup" href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" rid-figpopup="fig03" rid-ob="ob-fig03">Fig. 3.</a></div><!--caption a7--><div class="caption"><p>In vivo binding of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs to FR on tubules for enhanced delivery to the fibrotic kidney 24 h postinjection into UUO mice (day 7 post-UUO surgery). (<em>A</em>) The schematic drawing portrays the flow of NPs in urine (filtered from glomerulus) along the renal tubule and the expression of some FRs on the apical side of renal tubules. (<em>B</em>) Light micrographs of silver-enhanced UUO kidney sections show localization of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs inside the lumen of tubules (orange arrow) and inside tubule cells (yellow arrow) for a selected fraction of tubules. (<em>C</em>) IHC staining shows that the inhomogeneous pattern of FR expression (brown) only found on selected tubule cells in the UUO kidney, resembling localization of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in selected tubules (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>A</em></span></a>). Representative images from n = 3 kidney sections from three mice/group. (<em>D</em>) ICP-MS results showed higher accumulation of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in UUO kidneys than Au<sub>3</sub>-PEG<sub>500</sub> NPs. %ID = percent injected dose. Data are from n = 6, across two experiments. (<em>E</em>) IHC staining of FR (brown) and confocal reflectance microscopy of UUO kidney sections revealed colocalization of Au reflectance signals (green) and FR on selected renal tubules for Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, but not Au<sub>3</sub>-PEG<sub>500</sub> NP. For (<em>B</em>), (<em>C</em>), and (<em>E</em>), locations of the glomerulus, renal tubule, and tubule lumen are annotated as &#x0201c;<em>g</em>&#x0201d;, &#x0201c;<em>t</em>&#x0201d;, and &#x0201c;<em>l</em>&#x0201d;; representative images from three kidney sections from each mouse, n = 3 mice/group. (<em>F</em>) Representative TEM images show the presence of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs (arrow) inside a tubule cell of the UUO kidney; higher magnification TEM images (<em>Right</em>) show the NPs as individual entities in the tubule. The middle picture shows the enlargement of the blue boxed area of the left (yellow frame), and the right picture shows the enlargement of the red boxed area of the middle (blue frame). Nu = nucleus, Cy = cytosol. (<em>G</em>) ICP-MS analysis of compartmentalized UUO and CL kidneys showed preferential localization of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in the tubules and interstitial space of the UUO kidney. Data are from n = 6, across two experiments. (<em>H</em>) Accumulation of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>z</sub> NPs increased with FA loading (z) in the UUO kidney, not CL kidney. Data are from n = 3, across one experiment. For (<em>D</em>), (<em>G</em>), and (<em>H</em>), statistical significance was evaluated using two-way ANOVA with Tukey&#x02019;s post hoc test for multiple comparison. All <em>P</em> values &#x02264; 0.05 are displayed on the graphs. All bars and error bars represent mean &#x000b1; SD.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig04" co-legend-rid="lgnd_fig04"><a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" rid-figpopup="fig04" rid-ob="ob-fig04"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140455662758272"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10589645_pnas.2305662120fig04.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pnas.2305662120fig04.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10589645/bin/pnas.2305662120fig04.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140455662758272"><a target="object" rel="noopener" href="/pmc/articles/PMC10589645/figure/fig04/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig04"><div><a class="figpopup" href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" rid-figpopup="fig04" rid-ob="ob-fig04">Fig. 4.</a></div><!--caption a7--><div class="caption"><p>Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs reduced kidney degeneration. (<em>A</em>) UUO mice were treated with a single i.v. dose of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, Au<sub>3</sub>-PEG<sub>500</sub> NP, saline, or free FA on day 7 post-UUO surgery, or daily intraperitoneal injections of Captopril from day 7 to day 14. All animals were killed on day 14. (<em>B</em>) Gross appearance of a kidney from naive mice and a CL kidney from UUO mice after treatment with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP. (<em>C</em>) UUO kidneys of mice treated with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs showed the least tissue degeneration. The area inside the dotted region indicates loss of tissue. (<em>D</em>) Histological images of UUO kidneys reveal that mice treated with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs had the least tubule injury (arrow). Circle: intact tubule. Representative images from three kidney sections from each mouse, n = 9 mice/group. Locations of the glomerulus, renal tubules, and tubule lumen are annotated as &#x0201c;<em>g</em>&#x0201d;, &#x0201c;<em>t</em>&#x0201d;, and &#x0201c;<em>l</em>&#x0201d;. Mice treated with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP had significantly (<em>E</em>) lower % of injured tubules and (<em>F</em>) higher UUO kidney-to-body weight ratio than those treated with saline. For (<em>E</em>), statistical significance was evaluated using the nonparametric Kruskal&#x02013;Wallis H test that does not require the assumption of normality. Data are from n = 5, across one experiment. For (<em>F</em>), statistical significance was evaluated using one-way ANOVA with Tukey&#x02019;s post hoc test for multiple comparison. Error bars represent mean &#x000b1; SD. Data are from n = 9, across two experiments. All <em>P</em> values &#x02264; 0.05 are displayed on the graph.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig05" co-legend-rid="lgnd_fig05"><a href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" rid-figpopup="fig05" rid-ob="ob-fig05"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140455699018864"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10589645_pnas.2305662120fig05.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pnas.2305662120fig05.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10589645/bin/pnas.2305662120fig05.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140455699018864"><a target="object" rel="noopener" href="/pmc/articles/PMC10589645/figure/fig05/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig05"><div><a class="figpopup" href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" rid-figpopup="fig05" rid-ob="ob-fig05">Fig. 5.</a></div><!--caption a7--><div class="caption"><p>Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP reduced fibrosis in the UUO kidney. UUO mice were treated with either a single i.v. dose of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub>, Au<sub>3</sub>-PEG<sub>500</sub> NPs, saline, or free FA on day 7 post-UUO surgery, or daily intraperitoneal injections of Captopril from day 7 to day 14. All animals were killed on day 14. (<em>A</em>) IHC images show the expression of type I collagen (brown), the major component of ECM. (<em>B</em>) Quantitative analysis of type I collagen in kidney sections based on the IHC data in (<em>A</em>). (<em>C</em>) Western blot analysis revealed significant inhibition of type I collagen upon treatment with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP. &#x0201c;100%&#x0201d; indicates the mean value of the type I collagen content from saline-treated mice. Data are from n = 5, across one experiment. Statistical significance was evaluated using the Mann&#x02013;Whitney <em>U</em> test. IHC images show the expression of (<em>D</em>) &#x003b1;-SMA (brown) and (<em>E</em>) CD3<sup>+</sup> cells (brown dot and red arrow). Quantitative analysis of (<em>F</em>) &#x003b1;-SMA (brown) and (<em>G</em>) CD3<sup>+</sup> cells in the kidney sections based on the IHC data in (<em>D</em>) and (<em>E</em>). Mice treated with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP had significantly lower (<em>B</em>) type I collagen area, (<em>F</em>) &#x003b1;-SMA area, and (<em>G</em>) CD3<sup>+</sup> cells than those treated with saline. For (<em>A</em>), (<em>D</em>), and (<em>E</em>), representative images from three kidney sections from each mouse, n = 9 mice/group. Locations of the glomerulus, renal tubule, and tubule lumen are annotated as &#x0201c;<em>g</em>&#x0201d;, &#x0201c;<em>t</em>&#x0201d;, and &#x0201c;<em>l</em>&#x0201d;. For (<em>B</em>), (<em>F</em>), and (<em>G</em>), statistical significance was evaluated using one-way ANOVA with Tukey&#x02019;s post hoc test for multiple comparison. All <em>P</em> values &#x02264; 0.05 are displayed on the graphs. All bars and error bars represent mean &#x000b1; SD.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig06" co-legend-rid="lgnd_fig06"><a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" rid-figpopup="fig06" rid-ob="ob-fig06"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140455658572960"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10589645_pnas.2305662120fig06.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pnas.2305662120fig06.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10589645/bin/pnas.2305662120fig06.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140455658572960"><a target="object" rel="noopener" href="/pmc/articles/PMC10589645/figure/fig06/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig06"><div><a class="figpopup" href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" rid-figpopup="fig06" rid-ob="ob-fig06">Fig. 6.</a></div><!--caption a7--><div class="caption"><p>Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP inhibited ECM-related genes and p-p38&#x003b1; in the UUO kidney. (<em>A</em>) UUO mice were treated with a single i.v. dose of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, saline, or free FA on day 7 post-UUO surgery and then killed on day 9. (<em>B</em>) Venn diagram of differentially expressed genes (DEGs) identified in pairwise comparisons between the three treatment groups (Q &#x0003c; 0.05). Numbers in the overlapping region between two or more circles indicate the number of DEGs shared between the pairwise comparisons. Note that &#x0201c;Group X vs. Group Y&#x0201d; shows statistically significant changes in RNA expression that were found in Group X with reference to Group Y as baseline. There are 169 common DEGs in the &#x0201c;Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP vs. saline&#x0201d; and &#x0201c;Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP vs. free FA&#x0201d; pairwise comparisons (red border in Venn diagram). (<em>C</em>) Of the 169 common DEGs, 18 of them have FPKM values &#x0003e; 2 for the UUO kidneys analyzed by RNA-seq. (<em>D</em>) The heatmap shows that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP treatment down-regulated genes related to collagen and up-regulated genes related to vesicle transport when compared to free FA and saline treatments. (<em>E</em> and <em>F</em>) Percent inhibition of p38&#x003b1; and MAPKAPK2 by Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> (black) and Au<sub>3</sub>-PEG<sub>500</sub> NP (red) using the Z-Lyte assay. (<em>G</em>) IC<sub>50</sub> values of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> and Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs. (<em>H</em>) Western blot analysis revealed significant inhibition of p-p38&#x003b1; upon treatment with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP when compared to saline. Data are from n = 3, across one experiment. (<em>I</em>) ELISA analysis of the UUO kidney revealed significant inhibition of p-p38&#x003b1; upon treatment with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP when compared to saline. Data are from n = 3, across one experiment. In (<em>H</em>) and (<em>I</em>), statistical significance was evaluated using the Mann&#x02013;Whitney <em>U</em> test. All <em>P</em> values &#x02264; 0.05 are displayed on the graphs. All bars and error bars represent mean &#x000b1; SD.</p></div></div></div><p class="p p-last">Next, we evaluated the effect of disease stage on delivery of Au<sub>x</sub>-PEG<sub>y</sub> NPs to the UUO kidney on days 7, 14, or 28 post-UUO surgery. On day 7 postsurgery, dilatation of collecting ducts was evident, and the tubular epithelial cells were flattened and lost their cuboidal shape (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S12</a>). On days 14 and 28 post-UUO surgery, less intact tubule segments and more deposition of ECM in the tubulointerstitial area were observed (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S13</a>). As fibrosis progressed, the UUO kidney became lighter due to loss of tissue mass, tubular injury, and cell death; conversely, the CL nonfibrotic kidney becomes heavier in response to functional renal compensatory changes caused by UUO surgery (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S14</a>). Our data showed that a later disease stage caused more severe fibrosis that disfavors NP delivery. Even when we normalized the amount of gold to %ID/g to eliminate any bias due to differences in tissue mass as a function of disease stage, we still observed much less accumulation of NPs in the UUO kidney of mice injected on day 28 than mice injected on day 7 for most NP sizes tested (<a href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Fig. 1<em>E</em></span></a>). The %ID in the UUO kidney on day 28 was nonzero, indicating accumulation of some NPs. We reasoned that fluid flow inside the tubule lumen does not vanish to zero upon UUO (<a href="#r19" rid="r19" class=" bibr popnode">19</a>), consistent with the reported renal clearance of gold NPs in UUO mice (<a href="#r14" rid="r14" class=" bibr popnode">14</a>). Also, we detected a similar negative correlation between disease stage and NP content in the liver (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S15</a>), but there was no significant effect of disease stage on blood pharmacokinetics (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S16</a>). More studies are required to decipher the effect of UUO surgery on bio&#x02013;nano interactions outside of the kidney. From these data, we selected day 7 post-UUO surgery as the disease stage for our later studies to ensure adequate retention of NPs in the fibrotic kidney.</p></div><div id="s3" class="sec"><p></p><h3 id="s3title" class="inline">In Vitro and Ex Vivo Binding of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP to Renal Tubules. </h3><p class="p p-first">Immunohistochemistry (IHC) analysis of kidney biopsies obtained from patients with varying degrees of renal fibrosis revealed that some fibrotic tubules had higher expression of FR than their adjacent healthy tissues (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Fig. 2<em>A</em></span></a>). In the fibrotic kidney of UUO mice, we likewise detected that only a selected fraction of renal tubules overexpresses FR (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Fig. 2<em>B</em></span></a>); such an expression pattern is distinct from the diffuse, homogenous expression of FR in the healthy and CL kidneys.</p><p>To prepare Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, we added bifunctional PEG<sub>500</sub> strands with a thiol group on one end and a FA molecule on the other end (HS-PEG<sub>500</sub>-FA) to an aqueous suspension of unmodified Au<sub>3</sub> NPs (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Fig. 2<em>C</em></span></a>). When compared to Au<sub>3</sub>-PEG<sub>500</sub> NP, Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP is slightly smaller in terms of hydrodynamic size (7.0 vs. 9.4 nm). Based on the method of PEG strand displacement, we detected fewer PEG strands in Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP than Au<sub>3</sub>-PEG<sub>500</sub> NP (81 vs. 32 strands/NP), noting that PEG<sub>500</sub>-FA is bulkier than methoxy-PEG<sub>500</sub>. We corroborated this trend using TGA (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix,</em> Table S3</a>) and TEM imaging with negative staining (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix,</em> Fig. S3</a>). Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP remains stable in 50% FBS at 37 &#x000b0;C (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix,</em> Fig. S6</a>) and is not cytotoxic to mouse primary renal tubule cells (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S8</a>). Importantly, Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP shares a similar profile of proteins bound as Au<sub>3</sub>-PEG<sub>500</sub> NPs upon incubation in blood from UUO mice. Polyacrylamide gel analysis and bicinchoninic acid assay revealed similar amounts of blood proteins bound to Au<sub>3</sub>-PEG<sub>500</sub> and Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP (~0.4 &#x003bc;g of proteins per cm<sup>2</sup> of NP surface; <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix,</em> Fig. S17 <em>A</em> and <em>B</em></a>); this protein density is of the same order of magnitude to that derived from the adsorption of antibodies to 4-nm gold NPs (<a href="#r28" rid="r28" class=" bibr popnode">28</a>). Liquid chromatography&#x02013;tandem mass spectrometry (LC-MS/MS) analysis showed that the most abundant serum proteins bound to both NP types, which account for ~60% of total proteins bound, were albumin, apolipoprotein-AI, transferrin, and immunoglobulin (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S17<em>C</em></a>). These data suggest that any difference in interactions of both NP types in the kidney is unlikely due to a difference in serum proteins bound. Next, ICP-MS measurements revealed 3.5-fold higher association of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP with primary renal tubule cells than Au<sub>3</sub>-PEG<sub>500</sub> NP in vitro (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S18</a>). Confocal images of primary tubule cells treated with Cyanine (Cy) 5.5-labeled NPs verified more abundant cellular entry of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP and stronger association with FRs than Au<sub>3</sub>-PEG<sub>500</sub> NP, as evidenced by a higher Pearson&#x02019;s correlation coefficient of the former (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Fig. 2<em>D</em></span></a>). Further, Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP bound to UUO kidney tissues more abundantly than Au<sub>3</sub>-PEG<sub>500</sub> NP ex vivo. When UUO kidney tissues were freshly diced to expose the tubule lumen and incubated with identical concentrations of NPs, ICP-MS measurements revealed 3.5-fold higher association of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP with the tissues than Au<sub>3</sub>-PEG<sub>500</sub> NP (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Fig. 2<em>E</em></span></a>). As renal tubules occupy ~88% of the total kidney volume (<a href="#r12" rid="r12" class=" bibr popnode">12</a>) and FR is mostly expressed on proximal tubules, these data suggest the binding of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP to renal tubules.</p><p class="p p-last">It is challenging to verify whether Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP specifically binds to FRs on renal tubules by competitive binding assays in vivo, because intact immunoglobulin blocking antibodies are too large (&#x0003e;10 nm) to cross the GFB for accessing the renal tubules (<a href="#r29" rid="r29" class=" bibr popnode">29</a>). Therefore, we sought to address its binding to FR on kidney tissues under serum-containing conditions ex vivo. Additionally, we included megalin, another receptor on proximal renal tubules for reabsorbing nutrients, to this ex vivo study because theoretical predictions made by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (<a href="#r30" rid="r30" class=" bibr popnode">30</a>) showed that albumin, the top serum protein bound to Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, is likely to interact with megalin (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S19</a>). Pretreatment of freshly diced UUO kidney tissues with antibodies against FR or megalin both lowered the tissue association of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs, but the reduction achievable by blocking FR was greater (<a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span>Fig. 2<em>F</em></span></a>). These data suggest that the bound serum proteins did not severely mask the binding of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP to FRs on renal tubules.</p></div><div id="s4" class="sec"><p></p><h3 id="s4title" class="inline">In Vivo Delivery of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP to the Tubules of the Fibrotic Kidney. </h3><p class="p p-first">To investigate whether Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP can be localized to renal tubules in vivo, we i.v. injected UUO mice with the NPs and examined their accumulation in the kidneys 24 h postinjection. Silver enhancement staining of UUO kidney sections shows that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs mainly accumulated in some tubule cells or were found inside the tubule lumen (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3 <em>A</em> and <em>B</em></span></a>), while Au<sub>3</sub>-PEG<sub>500</sub> NPs were mainly found in the tubule lumen or interstitial space (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S20 and S21</a>). These images suggest that the NPs were flowing through the tubules after glomerular filtration at animal killing. Importantly, the distribution pattern of silver-stained Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in selected renal tubules of the UUO kidney is consistent with the distribution pattern of FR overexpression on selected renal tubules in <a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>C</em></span></a>. ICP-MS data showed that significantly more Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs (3.6 %ID) accumulated in the UUO kidney than Au<sub>3</sub>-PEG<sub>500</sub> NPs (1.0 %ID), while similar amounts of Au<sub>3</sub>-PEG<sub>500</sub> NPs (0.8 %ID) and Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs (0.7 %ID) were seen in the CL kidney (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>D</em></span></a>). We also detected gold in the urine samples for both NP types, suggesting their renal clearance (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S10</a>). To verify the selective delivery to the fibrotic kidney, we showed that under the same experimental conditions, only 1.0 %ID of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs accumulated in each kidney of healthy Balb/c mice (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S22</a>). Next, we investigated whether the overexpression of FR by some tubules contributes to the increased uptake of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs by the tubules in the UUO kidneys. FRs in the UUO kidney section were stained by IHC and Au cores were imaged by confocal reflectance microscopy. Notably, the Au reflectance signal and FRs on the tubules were localized only for the Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP sample but not the Au<sub>3</sub>-PEG<sub>500</sub> NP sample (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>E</em></span></a>), demonstrating that Au<sub>3</sub>-PEG<sub>500</sub>-FA NPs bound to FRs on tubules. TEM imaging with energy dispersive X-ray spectroscopy confirmed the localization of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs inside tubule cells (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>F</em></span></a> and <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S23</a>). A representative enlarged TEM image portrays individual Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in the tubule, suggesting their colloidal stability in vivo. If these NPs were to become aggregated after injection into the bloodstream, we reasoned that they would become too large to cross the GFB and enter the renal tubules. Further, to quantify the tissue-level distribution of the NPs, we separated the glomeruli, tubules, and tubulointerstitial space from the UUO and CL kidneys (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S24 and S25</a>) and measured their respective Au contents using ICP-MS. While significantly more Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs accumulated in the tubules and tubulointerstitial cells of the UUO kidney (1.0 %ID) than the CL kidney (0.2 %ID), the accumulation of Au<sub>3</sub>-PEG<sub>500</sub> NPs in both UUO (0.4 %ID) and CL (0.3 %ID) kidneys were similar (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>G</em></span></a>). Significantly more Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs (1.5 %ID) than Au<sub>3</sub>-PEG<sub>500</sub> NPs (0.8 %ID) were detected in the interstitial space of the UUO kidney, matching the enhanced uptake of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs by renal tubules and suggesting transcytosis of NPs from renal tubules to interstitial space. Neither Au<sub>3</sub>-PEG<sub>500</sub> nor Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs accumulated significantly in the glomeruli of UUO and CL kidneys, and accumulation in the CL kidneys was similar for both NP types (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>G</em></span></a>). Last, we prepared Au<sub>3</sub>-PEG<sub>500</sub>-FA NPs with different FA loadings (z) by adding different ratios of methoxy-terminated thiolated PEG and FA-terminated thiolated PEG to citrate-capped Au<sub>3</sub> NPs. These Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>z</sub> NPs have similar hydrodynamic diameters of ~7 nm and are stable in 50% FBS. Notably, NP accumulation in the UUO kidney positively correlated with FA loading (<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>H</em></span></a>); the accumulation of Au<sub>3</sub>-PEG<sub>500</sub>, Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>8</sub>, Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>16</sub>, and Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in the UUO kidney were 1.0 %ID, 1.2 %ID, 2.1 %ID, and 3.6 %ID, respectively. No such correlation was seen with the CL kidney. Taken together, our data demonstrate that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs showed enhanced delivery to the tubules of the fibrotic kidney.</p><p class="p p-last">Because FA is negatively charged and negatively charged polymers can accumulate in the kidney (<a href="#r31" rid="r31" class=" bibr popnode">31</a>), we explored the potential confounding effect of surface charge on delivery to the kidney. We injected Au<sub>3</sub>-PEG<sub>500</sub>-COOH NPs that contain a carboxylate group in the distal end of each PEG chain; this NP has a similar size to Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP but a more negative surface charge (&#x02212;13.5 vs. &#x02212;23.7 mV). The accumulation of Au<sub>3</sub>-PEG<sub>500</sub>-COOH NPs in the UUO kidney (1.9 %ID) was higher than that of Au<sub>3</sub>-PEG<sub>500</sub> NPs (1.0 %ID) but lower than that of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs (3.6% ID), suggesting that negative surface charge alone does not primarily account for the superior delivery of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs to the UUO kidney (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S26 and S27</a>). Finally, it is challenging to experimentally pinpoint the exact route of delivery of NPs to the UUO kidney. As Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> and Au<sub>3</sub>-PEG<sub>500</sub> NPs are similarly sized to the size cutoff of soft biomolecules passing through the GFB [~10 nm; (<a href="#r32" rid="r32" class=" bibr popnode">32</a>)] and the pore size of peritubular capillaries (<a href="#r33" rid="r33" class=" bibr popnode">33</a>), they may reach the interstitial space either via transcytosis from renal tubules or via extravasation from peritubular capillaries. Still, we reasoned that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP most likely crosses the GFB to enter renal tubules and later the interstitial space because it can bind to FRs on renal tubules and FR is mostly found on the apical side of proximal tubules (<a href="#r34" rid="r34" class=" bibr popnode">34</a>).</p></div><div id="s5" class="sec"><p></p><h3 id="s5title" class="inline">In Vivo Reduction of Kidney Degeneration and Renal Fibrosis by Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP. </h3><p class="p p-first">For our efficacy studies, we i.v. injected a single dose of NP (2.5 mg-Au/kg-mouse) to UUO mice with established renal fibrosis (day 7 post-UUO surgery). Seven days later (day 14) when severe renal fibrosis is expected, the animals were killed. Controls included Au<sub>3</sub>-PEG<sub>500</sub> NP without FA (2.5 mg-Au/kg-mouse), free FA without gold (0.12 mg-FA/kg-mouse; same FA dosage as Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP), saline, and Captopril [5 mg-drug/kg-mouse/day (<a href="#r35" rid="r35" class=" bibr popnode">35</a>)] (<a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig04" rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span>Fig. 4<em>A</em></span></a>). Our FA dosage is ~2,000 times lower than the dosage that can induce kidney injury by forming FA crystals in the tissue (<a href="#r36" rid="r36" class=" bibr popnode">36</a>), so we do not expect toxicity induced by FA in our treatment. To validate this claim, we histologically examined the major internal organs and performed hematology tests to show that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP was nontoxic up to 7 d postinjection into UUO mice (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S28&#x02013;S31</a>). IHC data confirmed that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP did not damage the CL kidney (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S32</a>), and serum creatinine levels remained in the normal range (<a href="#r37" rid="r37" class=" bibr popnode">37</a>) as UUO mice still have a functioning CL kidney (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S33</a>). We verified that the endotoxin levels of Au<sub>3</sub>-PEG<sub>500</sub> and Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP (0.01 and 0.003 EU/mL, respectively; <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Table S5</a>) were lower than the upper limit stipulated for preclinical research (1 EU/mL for injecting into a 20-g mouse over a 24-h time window) (<a href="#r38" rid="r38" class=" bibr popnode">38</a>).</p><p>Gross comparison of kidneys from healthy mice and CL kidneys from UUO mice (<a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig04" rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span>Fig. 4<em>B</em></span></a>) with UUO kidneys showed that only Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP rescued the UUO kidney from tissue degeneration, but Au<sub>3</sub>-PEG<sub>500</sub> NP, free FA, Captopril, or saline did not (<a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig04" rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span>Fig. 4<em>C</em></span></a>). Corroborating histological images revealed that only Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP significantly reduced the fraction of injured renal tubules (as evidenced by dilated tubules and loss of cytoplasm) when compared to saline (58%; <a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig04" rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span>Fig. 4 <em>D</em> and <em>E</em></span></a>). Tissue degeneration was quantified by measuring the UUO kidney weight of each mouse and normalizing it to its body weight (<a href="/pmc/articles/PMC10589645/figure/fig04/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig04" rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span>Fig. 4<em>F</em></span></a>). Mice treated with Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP had a significantly higher kidney-to-body weight ratio than those treated with saline or Au<sub>3</sub>-PEG<sub>500</sub> NP, but we cannot exclude any potential contribution of edema to the increased kidney weight.</p><p>We evaluated whether Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP can treat renal fibrosis. The primary treatment outcome is the level of type I collagen, the main component of fibrous scar (<a href="#r1" rid="r1" class=" bibr popnode">1</a>). IHC analysis showed that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP significantly reduced the (5.0%) fractional area of type I collagen in the UUO kidney when compared with saline (13.1%), but Au<sub>3</sub>-PEG<sub>500</sub> NP (11.7%), Captopril (13.5%), and free FA (11.2%) did not (<a href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig05" rid-ob="ob-fig05" co-legend-rid="lgnd_fig05"><span>Fig. 5 <em>A</em> and <em>B</em></span></a>). Here, Captopril did not treat renal fibrosis probably because, like Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, we injected Captopril after the establishment of fibrosis; past evidence of the antifibrotic effect of Captopril was preventive and based on simultaneous Captopril administration and fibrosis development (<a href="#r39" rid="r39" class=" bibr popnode">39</a>). western blot data confirmed that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP attenuated the type I collagen content in the UUO kidney by ~10-fold when compared to saline (<a href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig05" rid-ob="ob-fig05" co-legend-rid="lgnd_fig05"><span>Fig. 5<em>C</em></span></a>). Next, we assessed the expression level of &#x003b1;-smooth muscle actin (&#x003b1;-SMA) in the UUO kidney. &#x003b1;-SMA<sup>+</sup> cells, such as myofibroblasts, are the primary source of ECM in fibrotic kidneys (<a href="#r40" rid="r40" class=" bibr popnode">40</a>). Like collagen, &#x003b1;-SMA lies downstream of the p38 MAPK signaling pathway (<a href="#r41" rid="r41" class=" bibr popnode">41</a>). IHC showed that the area with positive &#x003b1;-SMA was significantly reduced only for Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP (8.8%) when compared with saline (14.3%) (<a href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig05" rid-ob="ob-fig05" co-legend-rid="lgnd_fig05"><span>Fig. 5 <em>D</em> and <em>F</em></span></a>). We then evaluated the population of CD3<sup>+</sup> T cells in the UUO kidney because T cell infiltration is a pathological feature of renal fibrosis (<a href="#r42" rid="r42" class=" bibr popnode">42</a>). Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP showed the most drastic reduction in the population of CD3<sup>+</sup> T cells (7 cells/frame) when compared to saline (21 cells/frame), while the levels of reduction by Au<sub>3</sub>-PEG<sub>500</sub> NP (15 cells/frame), Captopril (16 cells/frame), or free FA (13 cells/frame) were less notable (<a href="/pmc/articles/PMC10589645/figure/fig05/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig05" rid-ob="ob-fig05" co-legend-rid="lgnd_fig05"><span>Fig. 5 <em>E</em> and <em>G</em></span></a>). These data support the antifibrotic efficacy of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP.</p><p class="p p-last">We believe that the therapeutic efficacy of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP primarily stems from the gold core for two reasons. To start with, past clinical studies reported a therapeutic effect of FA for CKD, but the data were inconsistent across different trials (<a href="#r43" rid="r43" class=" bibr popnode">43</a><a href="#r44" rid="r44" class=" bibr popnode"></a>&#x02013;<a href="#r45" rid="r45" class=" bibr popnode">45</a>). Moreover, we compared the efficacy of Au<sub>3</sub>-PEG<sub>500</sub> NP injected at a ~3.5-fold higher dose (~8.8 mg-Au/kg-mouse) to that of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP injected at the original dose. This experiment serves to compensate for the less efficient delivery of Au<sub>3</sub>-PEG<sub>500</sub> NP to the UUO kidney than Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP (1.0% vs. 3.6% ID; <a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>Fig. 3<em>D</em></span></a>) and to ensure a similar absolute mass of Au to be delivered for both NP types, as confirmed by ICP-MS (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S34</a>). Notably, a 3.5-fold higher dose of Au<sub>3</sub>-PEG<sub>500</sub> NP reduced tissue degeneration and fibrosis at a similar efficacy as Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP at the original dose (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S35 and S36</a>), so we surmise that Au<sub>3</sub>-PEG<sub>500</sub> NP injected at the original dose did not reach the therapeutic window. Thus, attachment of FAs enhanced the delivery and efficacy of the gold cores without requiring more gold to be injected.</p></div><div id="s6" class="sec sec-last"><p></p><h3 id="s6title" class="inline">Mechanism for the Antifibrotic Efficacy of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP. </h3><p class="p p-first">We performed RNA sequencing (RNA-seq) analysis to elucidate the changes in RNA expression in the UUO kidney 2 d postinjection of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, free FA, or saline (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6<em>A</em></span></a>). This earlier time point than our efficacy study serves to avoid any degradation or translation of mRNA. RNA-seq analysis reveals &#x0003c;800 differentially expressed genes (DEGs) that were enriched in the pairwise comparison between Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP and saline (Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP vs. saline) and the pairwise comparison between Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP and free FA (Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP vs. free FA), suggesting that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP treatment did not cause pronounced off-target gene regulation (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6<em>B</em></span></a>). Of the 169 overlapping genes found in both pairwise comparisons, only 18 out of them have values of fragments per kilobase of transcript per million mapped reads (FPKM) &#x0003e;2 in the UUO kidneys (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6<em>C</em></span></a>); see detailed explanation in <em><a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Materials and Methods</a></em>). The gene ontology (GO) terms associated with these 18 genes include collagen-containing ECM (Colec12 and Vwa5a), extracellular space (Lamb2 and Tpm1), and apical membrane (Cldn7). Notably, the type I collagen (Col1a1) gene was significantly down-regulated in the Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP group when compared to the saline and free FA groups (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6<em>D</em></span></a> and <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix,</em> Table S6</a>). IHC staining of the UUO kidneys showed Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP group had a lower fractional area of type I collagen than the free FA or saline groups 2 d postinjection (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S37 and S38</a>), validating our RNA-seq data. These data suggest that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs suppressed ECM-associated genes more effectively than free FA or saline and underscore the therapeutic role of the gold core. Further, both pairwise comparisons yielded enriched GO terms of &#x0201c;apicolateral plasma membrane&#x0201d; and &#x0201c;brush border membrane&#x0201d; (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Figs. S39&#x02013;S41</a>), and the genes involved were Slc22a7 (a transporter of organic anions) and CD36 (which can bind to negatively charged ligands) (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6<em>D</em></span></a>). This result reinforces our postulate that anionic Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP enters renal tubules from the apical side (tubule lumen) after crossing the GFB.</p><p class="p p-last">Last, we conducted a kinome screen to identify kinases whose activities were inhibited by Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP. Of the 280 kinases tested, an NP concentration of 200 nM inhibited 27 kinases by &#x0003e;80% (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Table S7</a>); a few of them were relevant to CKD, including p38&#x003b1;, its downstream MAPK-activated protein kinase 2 (MAPKAPK2) (<a href="#r46" rid="r46" class=" bibr popnode">46</a>), G-protein-coupled receptor kinase 4 [GRK4; which is up-regulated after kidney injury (<a href="#r47" rid="r47" class=" bibr popnode">47</a>)] and ribosomal S6 kinase 2 [RSK2; which is linked to survival of immune cells in the fibrotic kidney (<a href="#r48" rid="r48" class=" bibr popnode">48</a>)] (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S42</a>). The half-maximal inhibitory concentrations (IC<sub>50</sub>&#x02019;s) of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP for p38&#x003b1; and MAPKAPK2 were 0.9 nM and 27.4 nM, respectively, indicating high potency of the NP (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6 <em>E</em>&#x02013;<em>G</em></span></a>). The IC<sub>50</sub>&#x02019;s of Au<sub>3</sub>-PEG<sub>500</sub> NP for both kinases were similar to those of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP, implying that inhibited p38&#x003b1; activity stems from the gold core. As the linkage between p38&#x003b1; and CKD is the most reported of all CKD-relevant kinases identified, we further proved that Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP treatment inhibited phosphorylated p38&#x003b1; (p-p38&#x003b1;) in the UUO kidney using western blot and enzyme-linked immunosorbent assay (ELISA) (<a href="/pmc/articles/PMC10589645/figure/fig06/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig06" rid-ob="ob-fig06" co-legend-rid="lgnd_fig06"><span>Fig. 6 <em>H</em> and <em>I</em></span></a>). This result validates the kinome profiling data and highlights the self-therapeutic mechanism of action of the 3-nm gold NP.</p></div></div><div id="s7" class="tsec sec"><h2 class="head no_bottom_margin" id="s7title" style="text-transform: uppercase;">Discussion</h2><p class="p p-first">We have presented a design [Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP (~7 nm)] to transport i.v. injected NPs into renal tubules, where tubulointerstitial fibrosis takes place. An NP size &#x0003c;10 nm supports delivery to renal tubules and FA conjugation supports binding to FRs on tubules. Past studies reported the use of larger &#x02265;20-nm gold NPs for alleviating diabetic nephropathy, another type of CKD (<a href="#r49" rid="r49" class=" bibr popnode">49</a>, <a href="#r50" rid="r50" class=" bibr popnode">50</a>) that stems from fibrosis in the glomerulus, but they are unsuitable for treating tubulointerstitial fibrosis because they are too large to reach the tubules. In contrast to previous studies on the organ-level distribution of sub-10-nm NPs to kidneys (~6 &#x000b5;g-gold/g-tissue) (<a href="#r51" rid="r51" class=" bibr popnode">51</a>), this work yields insights into their tissue- and cellular-level transport to renal tubules, an emerging trend in kidney nanomedicine (<a href="#r52" rid="r52" class=" bibr popnode">52</a>). The overexpression of FRs was only found on selected tubules in the fibrotic kidney, but it suffices to boost the retention of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NPs in the fibrotic kidney up to 3.6% ID (or 28.8 &#x000b5;g-gold/g-tissue), a pronounced improvement in delivery. FRs are expressed at very low levels in most tissues, except for placenta for embryonic development, kidney for folate resorption, and tumor to meet the folate demand of rapidly dividing cells (<a href="#r53" rid="r53" class=" bibr popnode">53</a>). While we believe that FA acts primarily as a targeting ligand for FRs to facilitate endocytosis by renal tubules (<a href="#r54" rid="r54" class=" bibr popnode">54</a>), it is unclear whether FA binding to fibrotic renal tubules contributes to antifibrotic efficacy. The exact signaling pathways of FRs are not fully understood, but there are some potential candidates (<a href="#r55" rid="r55" class=" bibr popnode">55</a>). Binding of FA to FRs can activate the extracellular signal-regulated kinase (ERK) (<a href="#r56" rid="r56" class=" bibr popnode">56</a>) and Janus kinase (JAK)-signal transducer and activator of transcription protein (STAT) pathways (<a href="#r57" rid="r57" class=" bibr popnode">57</a>) that are related to the growth, differentiation, and survival of cancer cells. Overall, this work not only improves our understanding in kidney&#x02013;NP interactions but also showcases the rational design of NPs based on disease pathophysiology (<a href="#r58" rid="r58" class=" bibr popnode">58</a>). Still, the applicability of our findings to other types of CKD remains to be addressed. The UUO model entails the retardation of fluid flow inside blocked tubules (<a href="#r59" rid="r59" class=" bibr popnode">59</a>) and overexpression of FRs on selected renal tubules, but both attractive features for cellular entry may not apply to other forms of CKD.</p><p>This work highlights the treatment potential of self-therapeutic gold nanomedicines for tubulointerstitial fibrosis. It lends credence to an emerging notion that gold NPs are self-therapeutic for a broad spectrum of diseases, such as cancer (<a href="#r60" rid="r60" class=" bibr popnode">60</a>) and skin inflammation (<a href="#r61" rid="r61" class=" bibr popnode">61</a>). Our treatment involved only one injection 7 d post-UUO surgery when fibrosis is established, in contrast to many existing preventive strategies that entailed multiple injections of drugs (<a href="#r62" rid="r62" class=" bibr popnode">62</a>) or drug-loaded NPs (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Table S1<em>A</em></a>) before fibrosis was established. Chitosan NPs complexed with siRNA against an inflammatory enzyme required injection 3 d prior to UUO surgery (<a href="#r9" rid="r9" class=" bibr popnode">9</a>). Albumin NPs loaded with small molecules that block p38 signaling entailed injection 2 d post-UUO surgery (<a href="#r63" rid="r63" class=" bibr popnode">63</a>). This point is of clinical importance; as early development of CKD is asymptomatic, patients are mostly diagnosed at a later disease stage. How 3-nm gold NPs mechanistically inhibit p38&#x003b1; and other CKD-related kinases will require further elucidation.</p><p class="p p-last">On clinical translation, the simple design and facile synthesis of Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP will be conducive to mass production. As PEG is a U.S. Food and Drug Administration (FDA)-cleared polymer used for drug delivery and FA is a common vitamin-based health supplement, the only potential regulatory hurdle will lie on gold NP. Concerns over gold-based therapies exist because gold, a heavy metal, may accumulate in tissues in the long run and past treatments that contained gold salts caused side effects (<a href="#r64" rid="r64" class=" bibr popnode">64</a>). Currently, gold NPs that facilitate the cellular delivery of biomolecules are under clinical tests. A phase 0 trial on patients with glioblastoma showed no severe toxicity upon i.v. infusion of RNA-conjugated gold NPs at microdose levels (<a href="#r65" rid="r65" class=" bibr popnode">65</a>), a reassuring result for gold NP-based therapies. Yet, because this RNA-conjugated gold NP remained in patient tumors that recurred up to 174 days posttrial enrollment, chrysiasis and other adverse events linked to long-term accumulation (<a href="#r66" rid="r66" class=" bibr popnode">66</a>) and biotransformation will need to be evaluated in humans. Here, there are two advantages of a 3-nm gold core. The Au<sub>3</sub>-PEG<sub>500</sub>-FA<sub>32</sub> NP can be cleared via renal and hepatobiliary pathways (<a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em>, Fig. S10</a>), and intracellular degradation of 3-nm gold NPs will be faster and require the generation of less reactive oxygen species than larger gold NPs (<a href="#r67" rid="r67" class=" bibr popnode">67</a>).</p></div><div id="s8" class="tsec sec"><h2 class="head no_bottom_margin" id="s8title" style="text-transform: uppercase;">Methods</h2><p class="p p-first">For detailed Materials and Methods, please see <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em></a>.</p><div id="s9" class="sec"><p></p><h3 id="s9title" class="inline">Animals. </h3><p class="p p-first-last">All procedures followed the guidelines stipulated by the Animal Experimentation Ethics Committee at The Chinese University of Hong Kong (CUHK). Male Balb/c mice between 8 and 12 wk of age were used and randomly divided into various treatment groups. All mice were housed in a temperature- and humidity-controlled environment with a 12-h light/dark cycle. For all distribution and efficacy studies, NPs or free FA were formulated in 100 &#x000b5;L of 5% dextrose (D5W; Sigma) for a single intravenous (i.v.) injection using a 29-gauge insulin syringe (Terumo). For all biodistribution and efficacy studies, the sample size (n) indicates biological replicates.</p></div><div id="s10" class="sec"><p></p><h3 id="s10title" class="inline">UUO. </h3><p class="p p-first-last">UUO surgery was performed as previously described (<a href="#r21" rid="r21" class=" bibr popnode">21</a>). Mice were anesthetized by an intraperitoneal injection of ketamine (100 mg/kg; Alfasan International B.V.) and xylazine (10 mg/kg; Alfasan International). The peritoneum was cut along the midline, and the left ureter was isolated and ligated twice using a 5-0 suture (NingBo Cheng-He Microsurgical Instruments). The bowel was laid back and the peritoneum was closed with suture. The mice were placed under a heating lamp to maintain body temperature until they recovered from anesthesia. For analgesia, three injections of buprenorphine (Temgesic, 0.05 mg/kg) were given to the mice subcutaneously every 12 h postsurgery. To verify the development of fibrosis, mice were killed by cervical dislocation with anesthesia, and kidneys were weighted and processed for histological analysis.</p></div><div id="s11" class="sec"><p></p><h3 id="s11title" class="inline">Sample Size Calculation for Efficacy Studies. </h3><p class="p p-first-last">We used Dunnett&#x02019;s test to deduce the required size of each treatment group (<em>N</em>) (<a href="#r68" rid="r68" class=" bibr popnode">68</a>). Dunnett&#x02019;s test is a multiple comparison procedure that compares the efficacy of each treatment group with the same control group. Here, we tested &#x0201c;H0: All treatment groups are equivalent to the control group&#x0201d; against &#x0201c;H1: There exists one group that is superior to the control group.&#x0201d; We compared the treatment groups and the control group in a way that i) the chance of committing type 1 error is &#x0003c;5% and that ii) our comparison is of power 80%. Dunnett&#x02019;s formalism states that <em>p</em> = &#x0221a;<em>N</em>&#x003b4;/&#x003c3;, where <em>p</em> is the correlation coefficient that depends on <em>N</em>. There are four treatment groups and a control group (i.e., saline), so <em>p</em> is 4.46 (<a href="#r56" rid="r56" class=" bibr popnode">56</a>). If the superior treatment group gives an outcome (<em>&#x003b4;</em>) of 1.5 SD (<em>&#x003c3;</em>) better than the control group, the required <em>N</em> is (4.46/1.5)<sup>2</sup> = 8.84 &#x02248; 9.</p></div><div id="s12" class="sec"><p></p><h3 id="s12title" class="inline">Efficacy. </h3><p class="p p-first-last">A single dose of Au<sub>3</sub>-PEG<sub>500</sub> NP, Au<sub>3</sub>-PEG<sub>500</sub>-FA NP, free FA (formulated in 0.1 mL of D5W), or saline was injected i.v. into UUO mice with established renal fibrosis (7 d post-UUO surgery) via the tail vein. FA was dissolved in sterile BioPerformance Certified dimethyl sulfoxide (DMSO; Sigma) and formulated in D5W prior to injection. The final concentration of DMSO was &#x0003c;1%. Au<sub>3</sub>-PEG<sub>500</sub>-FA NPs formulated in D5W was injected i.v. at a dose of 0.12 mg-FA/kg-mouse (or equivalently 2.5 mg-Au/kg-mouse). Au<sub>3</sub>-PEG<sub>500</sub> NPs were injected i.v. as a vehicle only control at a dosage of 2.5 mg-Au/kg-mouse. Saline was injected i.v. as a negative control. Captopril (Tokyo Chemical Industry) was injected intraperitoneally (i.p) at a dose of 5 mg/kg daily beginning on day 7 post-UUO surgery for 7 d (<a href="#r30" rid="r30" class=" bibr popnode">30</a>). Mice in all groups were killed on day 14 post-UUO surgery (7 d posttreatment), with n = 9 per group. All treated mice were anesthetized and killed by cervical dislocation 7 d posttreatment. For blood collection, mice were anesthetized, and blood was collected via cardiac puncture into plain tubes for serum collection. The kidneys were dissected, and the ureters were removed before weighing. The remaining kidney tissue was fixed in 10% buffered formalin for histological analysis.</p></div><div id="s13" class="sec sec-last"><p></p><h3 id="s13title" class="inline">Data Processing and Analysis. </h3><p class="p p-first-last">The Prism (GraphPad Software), Excel software, and SPSS software were used for data analysis and graph construction. Comparison of equivalence between multiple treatment groups and the untreated control group was computed by Dunnett&#x02019;s test and one-way ANOVA using the SPSS software. All results are biological replicates (unless specified). For ANOVA analysis, Tukey&#x02019;s post hoc test (with 95% confidence level) was used for multiple comparisons when the result was significant (<em>P</em> &#x0003c; 0.05). Normality of sampling distribution of means was validated by the Kolmogorov&#x02013;Smirnov test. There are no outliers outside 3 SD. Homogeneity of variance was validated by Levene&#x02019;s test.</p></div></div><div id="sec-a.k.h" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.k.htitle" style="text-transform: uppercase;">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="supplementary-material-a.k.h.b"><p>Appendix 01 (PDF)</p><div class="sup-box half_rhythm" id="media-a.k.h.b.b"><a href="/pmc/articles/PMC10589645/bin/pnas.2305662120.sapp.pdf" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(6.1M, pdf)</sup></div></div></div><div id="ack-a.l.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.l.atitle" style="text-transform: uppercase;">Acknowledgments</h2><div class="sec"><p>We thank Josie Lai, Anny Cheung, and Carol Yan from the School of Biomedical Sciences at CUHK for guidance in TEM, Helen Tsai from the School of Life Sciences for assistance in ultracentrifugation, Man Hau Yeung from the Department of Physics for assistance in thermogravimetric analysis, and Eason Ng from the Department of Surgery for assistance in illustration design. Schematics shown in <a href="/pmc/articles/PMC10589645/figure/fig01/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Figs. 1</span></a><a href="/pmc/articles/PMC10589645/figure/fig02/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">1</span></span><span></span></a>&#x02013;<a href="/pmc/articles/PMC10589645/figure/fig03/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span>3</span></a> were created using BioRender. This work was supported by the Hong Kong Research Grants Council Area of Excellence Scheme (Ref. AoE/M-401/20) and Research Matching Grant Scheme, Hong Kong Innovation and Technology Commission Midstream Research Program (Ref. MRP/054/20X), Chow Yuk Ho Technology Centre for Innovative Medicine, and a Vice-Chancellor Discretionary Fund at CUHK. C.H.J.C. thanks the Croucher Foundation for a Croucher Innovation Award. We thank Ai Lin Chun (Science Storylab) and Siu Tim Cheung, Jianfang Wang, Xiaohong Zhuang, and Lei Zhang (CUHK) for discussions.</p><div id="s15" class="sec"><p></p><h3 id="s15title" class="inline">Author contributions </h3><p class="p p-first-last">C.K.W.C., C.C.S., T.W.Y.L., and C.H.J.C. designed research; C.K.W.C., L.K.C.L., Y.X., and B.Y. performed research; C.C.S. contributed new reagents/analytic tools; C.K.W.C., C.C.S., L.K.C.L., X.D., J.Y.W.L., and C.H.J.C. analyzed data; and C.K.W.C. and C.H.J.C. wrote the paper.</p></div><div id="s16" class="sec sec-last"><p></p><h3 id="s16title" class="inline">Competing interests </h3><p class="p p-first-last">C.K.W.C., J.Y.W.L., and C.H.J.C. declare a patent pending on the delivery technique to the kidney and antifibrotic efficacy of the nanoparticle in the United States (63/104,262).</p></div></div></div><div id="fn-group-a.l.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.l.btitle" style="text-transform: uppercase;">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn2"><p class="p p-first-last">This article is a PNAS Direct Submission.</p></p></div></div><div id="s14" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="s14title" style="text-transform: uppercase;">Data, Materials, and Software Availability</h2><!--/article/back/sec/--><p class="p p-first-last">All study data are included in the article and/or <a href="http://www.pnas.org/lookup/doi/10.1073/pnas.2305662120#supplementary-materials" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank"><em>SI Appendix</em></a>.</p></div><div id="s17" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="s17title" style="text-transform: uppercase;">Supporting Information</h2><!--/article/back/sec/--></div><div id="ref-list-a.l.d" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.l.dtitle" style="text-transform: uppercase;">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="r1">1. <span class="mixed-citation">Liu Y., <span class="ref-title">Renal fibrosis: New insights into the pathogenesis and therapeutics</span>. <span class="ref-journal">Kidney Int.</span>
<span class="ref-vol"><strong>69</strong></span>, 213&#x02013;217 (2006). [<a href="https://pubmed.ncbi.nlm.nih.gov/16408108" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int.&amp;title=Renal+fibrosis:+New+insights+into+the+pathogenesis+and+therapeutics&amp;volume=69&amp;publication_year=2006&amp;pages=213-217&amp;pmid=16408108&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r2">2. <span class="mixed-citation">Veenstra D. L., Best J. H., Hornberger J., Sullivan S. D., Hricik D. E., <span class="ref-title">Incidence and long-term cost of steroid-related side effects after renal transplantation</span>. <span class="ref-journal">Am. J. Kidney Dis.</span>
<span class="ref-vol"><strong>33</strong></span>, 829&#x02013;839 (1999). [<a href="https://pubmed.ncbi.nlm.nih.gov/10213637" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Kidney+Dis.&amp;title=Incidence+and+long-term+cost+of+steroid-related+side+effects+after+renal+transplantation&amp;volume=33&amp;publication_year=1999&amp;pages=829-839&amp;pmid=10213637&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r3">3. <span class="mixed-citation">Fried L. F., et al., <span class="ref-title">Combined angiotensin inhibition for the treatment of diabetic nephropathy</span>. <span class="ref-journal">N. Engl. J. Med.</span>
<span class="ref-vol"><strong>369</strong></span>, 1892&#x02013;1903 (2013). [<a href="https://pubmed.ncbi.nlm.nih.gov/24206457" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=Combined+angiotensin+inhibition+for+the+treatment+of+diabetic+nephropathy&amp;volume=369&amp;publication_year=2013&amp;pages=1892-1903&amp;pmid=24206457&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r4">4. <span class="mixed-citation">Choi C. H. J., Zuckerman J. E., Webster P., Davis M. E., <span class="ref-title">Targeting kidney mesangium by nanoparticles of defined size</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A.</span>
<span class="ref-vol"><strong>108</strong></span>, 6656&#x02013;6661 (2011). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3080986/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21464325" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=Targeting+kidney+mesangium+by+nanoparticles+of+defined+size&amp;volume=108&amp;publication_year=2011&amp;pages=6656-6661&amp;pmid=21464325&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r5">5. <span class="mixed-citation">Huang Y., Jiang K., Zhang X., Chung E. J., <span class="ref-title">The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles</span>. <span class="ref-journal">Bioeng. Transl. Med.</span>
<span class="ref-vol"><strong>5</strong></span>, e10173 (2020). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7510478/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33005739" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioeng.+Transl.+Med.&amp;title=The+effect+of+size,+charge,+and+peptide+ligand+length+on+kidney+targeting+by+small,+organic+nanoparticles&amp;volume=5&amp;publication_year=2020&amp;pages=e10173&amp;pmid=33005739&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r6">6. <span class="mixed-citation">Williams R. M., et al., <span class="ref-title">Selective nanoparticle targeting of the renal tubules</span>. <span class="ref-journal">Hypertension</span>
<span class="ref-vol"><strong>71</strong></span>, 87&#x02013;94 (2018). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5730475/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29133360" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Selective+nanoparticle+targeting+of+the+renal+tubules&amp;volume=71&amp;publication_year=2018&amp;pages=87-94&amp;pmid=29133360&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r7">7. <span class="mixed-citation">Kamaly N., He J. C., Ausiello D. A., Farokhzad O. C., <span class="ref-title">Nanomedicines for renal disease: Current status and future applications</span>. <span class="ref-journal">Nat. Rev. Nephrol.</span>
<span class="ref-vol"><strong>12</strong></span>, 738&#x02013;753 (2016). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5593312/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27795549" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Nephrol.&amp;title=Nanomedicines+for+renal+disease:+Current+status+and+future+applications&amp;volume=12&amp;publication_year=2016&amp;pages=738-753&amp;pmid=27795549&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r8">8. <span class="mixed-citation">Hewitson T. D., <span class="ref-title">Renal tubulointerstitial fibrosis: Common but never simple</span>. <span class="ref-journal">Am. J. Physiol. Renal Physiol.</span>
<span class="ref-vol"><strong>296</strong></span>, 1239&#x02013;1244 (2009). [<a href="https://pubmed.ncbi.nlm.nih.gov/19144691" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Physiol.+Renal+Physiol.&amp;title=Renal+tubulointerstitial+fibrosis:+Common+but+never+simple&amp;volume=296&amp;publication_year=2009&amp;pages=1239-1244&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r9">9. <span class="mixed-citation">Yang C., et al., <span class="ref-title">Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice</span>. <span class="ref-journal">Theranostics</span>
<span class="ref-vol"><strong>5</strong></span>, 110&#x02013;123 (2015). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4278998/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25553102" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Chitosan/siRNA+nanoparticles+targeting+cyclooxygenase+type+2+attenuate+unilateral+ureteral+obstruction-induced+kidney+injury+in+mice&amp;volume=5&amp;publication_year=2015&amp;pages=110-123&amp;pmid=25553102&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r10">10. <span class="mixed-citation">Wang J., et al., <span class="ref-title">Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease</span>. <span class="ref-journal">J. Control. Release</span>
<span class="ref-vol"><strong>329</strong></span>, 1198&#x02013;1209 (2021). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7904655/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33127449" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Control.+Release&amp;title=Oral+delivery+of+metformin+by+chitosan+nanoparticles+for+polycystic+kidney+disease&amp;volume=329&amp;publication_year=2021&amp;pages=1198-1209&amp;pmid=33127449&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r11">11. <span class="mixed-citation">Huang C., et al., <span class="ref-title">Folate receptor-mediated renal-targeting nanoplatform for the specific delivery of triptolide to treat renal ischemia/reperfusion injury</span>. <span class="ref-journal">ACS Biomater. Sci. Eng.</span>
<span class="ref-vol"><strong>5</strong></span>, 2877&#x02013;2886 (2019). [<a href="https://pubmed.ncbi.nlm.nih.gov/33405591" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Biomater.+Sci.+Eng.&amp;title=Folate+receptor-mediated+renal-targeting+nanoplatform+for+the+specific+delivery+of+triptolide+to+treat+renal+ischemia/reperfusion+injury&amp;volume=5&amp;publication_year=2019&amp;pages=2877-2886&amp;pmid=33405591&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r12">12. <span class="mixed-citation">Zuckerman J. E., Choi C. H. J., Han H., Davis M. E., <span class="ref-title">Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A.</span>
<span class="ref-vol"><strong>109</strong></span>, 3137&#x02013;3142 (2012). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3286910/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22315430" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=Polycation-siRNA+nanoparticles+can+disassemble+at+the+kidney+glomerular+basement+membrane&amp;volume=109&amp;publication_year=2012&amp;pages=3137-3142&amp;pmid=22315430&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r13">13. <span class="mixed-citation">Choi H. S., et al., <span class="ref-title">Renal clearance of quantum dots</span>. <span class="ref-journal">Nat. Biotechnol.</span>
<span class="ref-vol"><strong>25</strong></span>, 1165&#x02013;1170 (2007). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2702539/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17891134" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Biotechnol.&amp;title=Renal+clearance+of+quantum+dots&amp;volume=25&amp;publication_year=2007&amp;pages=1165-1170&amp;pmid=17891134&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r14">14. <span class="mixed-citation">Yu M., et al., <span class="ref-title">Noninvasive staging of kidney dysfunction enabled by renal-clearable luminescent gold nanoparticles</span>. <span class="ref-journal">Angew. Chem. Int. Ed.</span>
<span class="ref-vol"><strong>55</strong></span>, 2787&#x02013;2791 (2016). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4834218/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26800513" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Angew.+Chem.+Int.+Ed.&amp;title=Noninvasive+staging+of+kidney+dysfunction+enabled+by+renal-clearable+luminescent+gold+nanoparticles&amp;volume=55&amp;publication_year=2016&amp;pages=2787-2791&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r15">15. <span class="mixed-citation">Trac N., et al., <span class="ref-title">Spotlight on genetic kidney diseases: A call for drug delivery and nanomedicine solutions</span>. <span class="ref-journal">ACS Nano</span>
<span class="ref-vol"><strong>17</strong></span>, 6165&#x02013;6177 (2023). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10145694/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36988207" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Nano&amp;title=Spotlight+on+genetic+kidney+diseases:+A+call+for+drug+delivery+and+nanomedicine+solutions&amp;volume=17&amp;publication_year=2023&amp;pages=6165-6177&amp;pmid=36988207&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r16">16. <span class="mixed-citation">Stambe C., et al., <span class="ref-title">The role of p38&#x003b1; mitogen-activated protein kinase activation in renal fibrosis</span>. <span class="ref-journal">J. Am. Soc. Nephrol.</span>
<span class="ref-vol"><strong>15</strong></span>, 370&#x02013;379 (2004). [<a href="https://pubmed.ncbi.nlm.nih.gov/14747383" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Soc.+Nephrol.&amp;title=The+role+of+p38&#x003b1;+mitogen-activated+protein+kinase+activation+in+renal+fibrosis&amp;volume=15&amp;publication_year=2004&amp;pages=370-379&amp;pmid=14747383&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r17">17. <span class="mixed-citation">Chevalier R. L., Forbes M. S., Thornhill B. A., <span class="ref-title">Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy</span>. <span class="ref-journal">Kidney Int.</span>
<span class="ref-vol"><strong>75</strong></span>, 1145&#x02013;1152 (2009). [<a href="https://pubmed.ncbi.nlm.nih.gov/19340094" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int.&amp;title=Ureteral+obstruction+as+a+model+of+renal+interstitial+fibrosis+and+obstructive+nephropathy&amp;volume=75&amp;publication_year=2009&amp;pages=1145-1152&amp;pmid=19340094&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r18">18. <span class="mixed-citation">Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D., <span class="ref-title">The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group</span>. <span class="ref-journal">N. Engl. J. Med.</span>
<span class="ref-vol"><strong>329</strong></span>, 1456&#x02013;1462 (1993). [<a href="https://pubmed.ncbi.nlm.nih.gov/8413456" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=The+effect+of+angiotensin-converting-enzyme+inhibition+on+diabetic+nephropathy.+The+collaborative+study+group&amp;volume=329&amp;publication_year=1993&amp;pages=1456-1462&amp;pmid=8413456&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r19">19. <span class="mixed-citation">Wahlberg J., Stenberg A., Wilson D. R., Persson A. E. G., <span class="ref-title">Tubuloglomerular feedback and interstitial pressure in obstructive nephropathy</span>. <span class="ref-journal">Kidney Int.</span>
<span class="ref-vol"><strong>26</strong></span>, 294&#x02013;301 (1984). [<a href="https://pubmed.ncbi.nlm.nih.gov/6513275" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int.&amp;title=Tubuloglomerular+feedback+and+interstitial+pressure+in+obstructive+nephropathy&amp;volume=26&amp;publication_year=1984&amp;pages=294-301&amp;pmid=6513275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r20">20. <span class="mixed-citation">Dolinina J., Rippe A., Bentzer P., &#x000d6;berg C. M., <span class="ref-title">Glomerular hyperpermeability after acute unilateral ureteral obstruction: Effects of Tempol, NOS, RhoA, and Rac-1 inhibition</span>. <span class="ref-journal">Am. J. Physiol. Renal Physiol.</span>
<span class="ref-vol"><strong>315</strong></span>, F445&#x02013;F453 (2018). [<a href="https://pubmed.ncbi.nlm.nih.gov/29465305" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Physiol.+Renal+Physiol.&amp;title=Glomerular+hyperpermeability+after+acute+unilateral+ureteral+obstruction:+Effects+of+Tempol,+NOS,+RhoA,+and+Rac-1+inhibition&amp;volume=315&amp;publication_year=2018&amp;pages=F445-F453&amp;pmid=29465305&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r21">21. <span class="mixed-citation">Del Pino P., et al., <span class="ref-title">Basic physicochemical properties of polyethylene glycol coated gold nanoparticles that determine their interaction with cells</span>. <span class="ref-journal">Angew. Chem. Int. Ed.</span>
<span class="ref-vol"><strong>55</strong></span>, 5483&#x02013;5487 (2016). [<a href="https://pubmed.ncbi.nlm.nih.gov/27028669" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Angew.+Chem.+Int.+Ed.&amp;title=Basic+physicochemical+properties+of+polyethylene+glycol+coated+gold+nanoparticles+that+determine+their+interaction+with+cells&amp;volume=55&amp;publication_year=2016&amp;pages=5483-5487&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r22">22. <span class="mixed-citation">Hurst S. J., Lytton-Jean A. K. R., Mirkin C. A., <span class="ref-title">Maximizing DNA loading on a range of gold nanoparticle sizes</span>. <span class="ref-journal">Anal. Chem.</span>
<span class="ref-vol"><strong>78</strong></span>, 8313&#x02013;8318 (2006). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2525614/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17165821" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal.+Chem.&amp;title=Maximizing+DNA+loading+on+a+range+of+gold+nanoparticle+sizes&amp;volume=78&amp;publication_year=2006&amp;pages=8313-8318&amp;pmid=17165821&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r23">23. <span class="mixed-citation">Ho L. W. C., et al., <span class="ref-title">Effect of alkylation on the cellular uptake of polyethylene glycol-coated gold nanoparticles</span>. <span class="ref-journal">ACS Nano</span>
<span class="ref-vol"><strong>11</strong></span>, 6085&#x02013;6101 (2017). [<a href="https://pubmed.ncbi.nlm.nih.gov/28562003" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Nano&amp;title=Effect+of+alkylation+on+the+cellular+uptake+of+polyethylene+glycol-coated+gold+nanoparticles&amp;volume=11&amp;publication_year=2017&amp;pages=6085-6101&amp;pmid=28562003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r24">24. <span class="mixed-citation">Liu H., et al., <span class="ref-title">Control of surface ligand density on PEGylated gold nanoparticles for optimized cancer cell uptake</span>. <span class="ref-journal">Part. Part. Syst. Charact.</span>
<span class="ref-vol"><strong>32</strong></span>, 197&#x02013;204 (2015). <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Part.+Part.+Syst.+Charact.&amp;title=Control+of+surface+ligand+density+on+PEGylated+gold+nanoparticles+for+optimized+cancer+cell+uptake&amp;volume=32&amp;publication_year=2015&amp;pages=197-204&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r25">25. <span class="mixed-citation">Ouyang B., et al., <span class="ref-title">The dose threshold for nanoparticle tumour delivery</span>. <span class="ref-journal">Nat. Mater.</span>
<span class="ref-vol"><strong>19</strong></span>, 1362&#x02013;1371 (2020). [<a href="https://pubmed.ncbi.nlm.nih.gov/32778816" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Mater.&amp;title=The+dose+threshold+for+nanoparticle+tumour+delivery&amp;volume=19&amp;publication_year=2020&amp;pages=1362-1371&amp;pmid=32778816&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r26">26. <span class="mixed-citation">Hesketh E. E., et al., <span class="ref-title">A murine model of irreversible and reversible unilateral ureteric obstruction</span>. <span class="ref-journal">J. Vis. Exp.</span>
<span class="ref-vol"><strong>94</strong></span>, 52559 (2014). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4396952/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25549273" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Vis.+Exp.&amp;title=A+murine+model+of+irreversible+and+reversible+unilateral+ureteric+obstruction&amp;volume=94&amp;publication_year=2014&amp;pages=52559&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r27">27. <span class="mixed-citation">Wu Z., Li X., Hou C., Qian Y., <span class="ref-title">Solubility of folic acid in water at pH values between 0 and 7 at temperatures (298.15, 303.15, and 313.15) K</span>. <span class="ref-journal">J. Chem. Eng. Data</span>
<span class="ref-vol"><strong>55</strong></span>, 3958&#x02013;3961 (2010). <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Chem.+Eng.+Data&amp;title=Solubility+of+folic+acid+in+water+at+pH+values+between+0+and+7+at+temperatures+(298.15,+303.15,+and+313.15)+K&amp;volume=55&amp;publication_year=2010&amp;pages=3958-3961&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r28">28. <span class="mixed-citation">Glancy D., et al., <span class="ref-title">Characterizing the protein corona of sub-10 nm nanoparticles</span>. <span class="ref-journal">J. Control Release</span>
<span class="ref-vol"><strong>304</strong></span>, 102&#x02013;110 (2019). [<a href="https://pubmed.ncbi.nlm.nih.gov/31004667" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Control+Release&amp;title=Characterizing+the+protein+corona+of+sub-10+nm+nanoparticles&amp;volume=304&amp;publication_year=2019&amp;pages=102-110&amp;pmid=31004667&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r29">29. <span class="mixed-citation">Covell D. G., et al., <span class="ref-title">Pharmacokinetics of monoclonal immunoglobulin G1, F(ab&#x02032;)2, and Fab&#x02032; in mice</span>. <span class="ref-journal">Cancer Res.</span>
<span class="ref-vol"><strong>46</strong></span>, 3969&#x02013;3978 (1986). [<a href="https://pubmed.ncbi.nlm.nih.gov/3731067" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=Pharmacokinetics+of+monoclonal+immunoglobulin+G1,+F(ab&#x02032;)2,+and+Fab&#x02032;+in+mice&amp;volume=46&amp;publication_year=1986&amp;pages=3969-3978&amp;pmid=3731067&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r30">30. <span class="mixed-citation">Ngo W., et al., <span class="ref-title">Identifying cell receptors for the nanoparticle protein corona using genome screens</span>. <span class="ref-journal">Nat. Chem. Biol.</span>
<span class="ref-vol"><strong>18</strong></span>, 1023&#x02013;1031 (2022). [<a href="https://pubmed.ncbi.nlm.nih.gov/35953550" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Chem.+Biol.&amp;title=Identifying+cell+receptors+for+the+nanoparticle+protein+corona+using+genome+screens&amp;volume=18&amp;publication_year=2022&amp;pages=1023-1031&amp;pmid=35953550&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r31">31. <span class="mixed-citation">Chen Y., et al., <span class="ref-title">Determinants of preferential renal accumulation of synthetic polymers in acute kidney injury</span>. <span class="ref-journal">Int. J. Pharm.</span>
<span class="ref-vol"><strong>568</strong></span>, 118555 (2019). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6708481/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31344445" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Pharm.&amp;title=Determinants+of+preferential+renal+accumulation+of+synthetic+polymers+in+acute+kidney+injury&amp;volume=568&amp;publication_year=2019&amp;pages=118555&amp;pmid=31344445&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r32">32. <span class="mixed-citation">Du B., Yu M., Zheng J., <span class="ref-title">Transport and interactions of nanoparticles in the kidneys</span>. <span class="ref-journal">Nat. Rev. Mater.</span>
<span class="ref-vol"><strong>3</strong></span>, 358&#x02013;374 (2018). <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Mater.&amp;title=Transport+and+interactions+of+nanoparticles+in+the+kidneys&amp;volume=3&amp;publication_year=2018&amp;pages=358-374&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r33">33. <span class="mixed-citation">Sarin H., <span class="ref-title">Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability</span>. <span class="ref-journal">J. Angiogenes. Res.</span>
<span class="ref-vol"><strong>2</strong></span>, 14 (2010). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2928191/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20701757" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Angiogenes.+Res.&amp;title=Physiologic+upper+limits+of+pore+size+of+different+blood+capillary+types+and+another+perspective+on+the+dual+pore+theory+of+microvascular+permeability&amp;volume=2&amp;publication_year=2010&amp;pages=14&amp;pmid=20701757&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r34">34. <span class="mixed-citation">Dolman M. E. M., Harmsen S., Storm G., Hennink W. E., Kok R. J., <span class="ref-title">Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells</span>. <span class="ref-journal">Adv. Drug Deliv. Rev.</span>
<span class="ref-vol"><strong>62</strong></span>, 1344&#x02013;1357 (2010). [<a href="https://pubmed.ncbi.nlm.nih.gov/20719242" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv.+Drug+Deliv.+Rev.&amp;title=Drug+targeting+to+the+kidney:+Advances+in+the+active+targeting+of+therapeutics+to+proximal+tubular+cells&amp;volume=62&amp;publication_year=2010&amp;pages=1344-1357&amp;pmid=20719242&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r35">35. <span class="mixed-citation">Nestor J., et al., <span class="ref-title">Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors</span>. <span class="ref-journal">J. Exp. Med.</span>
<span class="ref-vol"><strong>215</strong></span>, 2554&#x02013;2566 (2018). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6170183/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30185634" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Exp.+Med.&amp;title=Lupus+antibodies+induce+behavioral+changes+mediated+by+microglia+and+blocked+by+ACE+inhibitors&amp;volume=215&amp;publication_year=2018&amp;pages=2554-2566&amp;pmid=30185634&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r36">36. <span class="mixed-citation">Yang H. C., Zuo Y., Fogo A. B., <span class="ref-title">Models of chronic kidney disease</span>. <span class="ref-journal">Drug Discov. Today Dis. Models</span>
<span class="ref-vol"><strong>7</strong></span>, 13&#x02013;19 (2010). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3030258/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21286234" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov.+Today+Dis.+Models&amp;title=Models+of+chronic+kidney+disease&amp;volume=7&amp;publication_year=2010&amp;pages=13-19&amp;pmid=21286234&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r37">37. <span class="mixed-citation">Keppler A., et al., <span class="ref-title">Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay</span>. <span class="ref-journal">Kidney Int.</span>
<span class="ref-vol"><strong>71</strong></span>, 74&#x02013;78 (2007). [<a href="https://pubmed.ncbi.nlm.nih.gov/17082757" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int.&amp;title=Plasma+creatinine+determination+in+mice+and+rats:+An+enzymatic+method+compares+favorably+with+a+high-performance+liquid+chromatography+assay&amp;volume=71&amp;publication_year=2007&amp;pages=74-78&amp;pmid=17082757&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r38">38. <span class="mixed-citation">Malyala P., Singh M., <span class="ref-title">Endotoxin limits in formulations for preclinical research</span>. <span class="ref-journal">J. Pharm. Sci.</span>
<span class="ref-vol"><strong>97</strong></span>, 2041&#x02013;2044 (2008). [<a href="https://pubmed.ncbi.nlm.nih.gov/17847072" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Pharm.+Sci.&amp;title=Endotoxin+limits+in+formulations+for+preclinical+research&amp;volume=97&amp;publication_year=2008&amp;pages=2041-2044&amp;pmid=17847072&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r39">39. <span class="mixed-citation">Chan G. C. W., et al., <span class="ref-title">N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice</span>. <span class="ref-journal">Nephrology</span>
<span class="ref-vol"><strong>23</strong></span>, 297&#x02013;307 (2018). [<a href="https://pubmed.ncbi.nlm.nih.gov/28075040" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrology&amp;title=N-acetyl-seryl-aspartyl-lysyl-proline+mediates+the+anti-fibrotic+properties+of+captopril+in+unilateral+ureteric+obstructed+BALB/C+mice&amp;volume=23&amp;publication_year=2018&amp;pages=297-307&amp;pmid=28075040&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r40">40. <span class="mixed-citation">Liu Y., <span class="ref-title">Cellular and molecular mechanisms of renal fibrosis</span>. <span class="ref-journal">Nat. Rev. Nephrol.</span>
<span class="ref-vol"><strong>7</strong></span>, 684&#x02013;696 (2011). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4520424/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22009250" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Nephrol.&amp;title=Cellular+and+molecular+mechanisms+of+renal+fibrosis&amp;volume=7&amp;publication_year=2011&amp;pages=684-696&amp;pmid=22009250&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r41">41. <span class="mixed-citation">Turner N. A., Blythe N. M., <span class="ref-title">Cardiac fibroblast p38 MAPK: A critical regulator of myocardial remodeling</span>. <span class="ref-journal">J. Cardiovasc. Dev. Dis.</span>
<span class="ref-vol"><strong>6</strong></span>, 27 (2019). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6787752/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31394846" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Cardiovasc.+Dev.+Dis.&amp;title=Cardiac+fibroblast+p38+MAPK:+A+critical+regulator+of+myocardial+remodeling&amp;volume=6&amp;publication_year=2019&amp;pages=27&amp;pmid=31394846&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r42">42. <span class="mixed-citation">Zeisberg M., Neilson E. G., <span class="ref-title">Mechanisms of tubulointerstitial fibrosis</span>. <span class="ref-journal">J. Am. Soc. Nephrol.</span>
<span class="ref-vol"><strong>21</strong></span>, 1819&#x02013;1834 (2010). [<a href="https://pubmed.ncbi.nlm.nih.gov/20864689" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Soc.+Nephrol.&amp;title=Mechanisms+of+tubulointerstitial+fibrosis&amp;volume=21&amp;publication_year=2010&amp;pages=1819-1834&amp;pmid=20864689&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r43">43. <span class="mixed-citation">Xu X., et al., <span class="ref-title">Efficacy of folic acid therapy on the progression of chronic kidney disease: The renal substudy of the China stroke primary prevention trial</span>. <span class="ref-journal">JAMA Intern. Med.</span>
<span class="ref-vol"><strong>176</strong></span>, 1443&#x02013;1450 (2016). [<a href="https://pubmed.ncbi.nlm.nih.gov/27548766" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA+Intern.+Med.&amp;title=Efficacy+of+folic+acid+therapy+on+the+progression+of+chronic+kidney+disease:+The+renal+substudy+of+the+China+stroke+primary+prevention+trial&amp;volume=176&amp;publication_year=2016&amp;pages=1443-1450&amp;pmid=27548766&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r44">44. <span class="mixed-citation">House A. A., et al., <span class="ref-title">Effect of B-vitamin therapy on progression of diabetic nephropathy: A randomized controlled trial</span>. <span class="ref-journal">J. Am. Med. Assoc.</span>
<span class="ref-vol"><strong>303</strong></span>, 1603&#x02013;1609 (2010). [<a href="https://pubmed.ncbi.nlm.nih.gov/20424250" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Med.+Assoc.&amp;title=Effect+of+B-vitamin+therapy+on+progression+of+diabetic+nephropathy:+A+randomized+controlled+trial&amp;volume=303&amp;publication_year=2010&amp;pages=1603-1609&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r45">45. <span class="mixed-citation">Jamison R. L., et al., <span class="ref-title">Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: A randomized controlled trial</span>. <span class="ref-journal">J. Am. Med. Assoc.</span>
<span class="ref-vol"><strong>298</strong></span>, 1163&#x02013;1170 (2007). [<a href="https://pubmed.ncbi.nlm.nih.gov/17848650" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Med.+Assoc.&amp;title=Effect+of+homocysteine+lowering+on+mortality+and+vascular+disease+in+advanced+chronic+kidney+disease+and+end-stage+renal+disease:+A+randomized+controlled+trial&amp;volume=298&amp;publication_year=2007&amp;pages=1163-1170&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r46">46. <span class="mixed-citation">Canovas B., Nebreda A. R., <span class="ref-title">Diversity and versatility of p38 kinase signalling in health and disease</span>. <span class="ref-journal">Nat. Rev. Mol. Cell Biol.</span>
<span class="ref-vol"><strong>22</strong></span>, 346&#x02013;366 (2021). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7838852/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33504982" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Mol.+Cell+Biol.&amp;title=Diversity+and+versatility+of+p38+kinase+signalling+in+health+and+disease&amp;volume=22&amp;publication_year=2021&amp;pages=346-366&amp;pmid=33504982&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r47">47. <span class="mixed-citation">Yang D., et al., <span class="ref-title">Downregulation of G protein&#x02013;coupled receptor kinase 4 protects against kidney ischemia-reperfusion injury</span>. <span class="ref-journal">Kidney Int.</span>
<span class="ref-vol"><strong>103</strong></span>, 719&#x02013;734 (2023). [<a href="https://pubmed.ncbi.nlm.nih.gov/36669643" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int.&amp;title=Downregulation+of+G+protein&#x02013;coupled+receptor+kinase+4+protects+against+kidney+ischemia-reperfusion+injury&amp;volume=103&amp;publication_year=2023&amp;pages=719-734&amp;pmid=36669643&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r48">48. <span class="mixed-citation">Lin L., Jin Y., Hu K., <span class="ref-title">Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathway</span>. <span class="ref-journal">J. Biol. Chem.</span>
<span class="ref-vol"><strong>290</strong></span>, 7910&#x02013;7917 (2015). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4367289/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25670857" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=Tissue-type+plasminogen+activator+(tPA)+promotes+M1+macrophage+survival+through+p90+ribosomal+S6+kinase+(RSK)+and+p38+mitogen-activated+protein+kinase+(MAPK)+pathway&amp;volume=290&amp;publication_year=2015&amp;pages=7910-7917&amp;pmid=25670857&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r49">49. <span class="mixed-citation">Alomari G., et al., <span class="ref-title">Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy</span>. <span class="ref-journal">Drug Deliv. Transl. Res.</span>
<span class="ref-vol"><strong>10</strong></span>, 216&#x02013;226 (2020). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6978433/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31637677" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Deliv.+Transl.+Res.&amp;title=Gold+nanoparticles+attenuate+albuminuria+by+inhibiting+podocyte+injury+in+a+rat+model+of+diabetic+nephropathy&amp;volume=10&amp;publication_year=2020&amp;pages=216-226&amp;pmid=31637677&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r50">50. <span class="mixed-citation">Manna K., et al., <span class="ref-title">Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: Assessment of NF-kappa B and Nrf2 signaling system</span>. <span class="ref-journal">Int. J. Nanomedicine</span>
<span class="ref-vol"><strong>14</strong></span>, 1753&#x02013;1777 (2019). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6413818/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30880978" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Nanomedicine&amp;title=Amelioration+of+diabetic+nephropathy+using+pomegranate+peel+extract-stabilized+gold+nanoparticles:+Assessment+of+NF-kappa+B+and+Nrf2+signaling+system&amp;volume=14&amp;publication_year=2019&amp;pages=1753-1777&amp;pmid=30880978&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r51">51. <span class="mixed-citation">Huo S., et al., <span class="ref-title">Ultrasmall gold nanoparticles behavior in vivo modulated by surface polyethylene glycol (PEG) grafting</span>. <span class="ref-journal">Bioconjug. Chem.</span>
<span class="ref-vol"><strong>28</strong></span>, 239&#x02013;243 (2017). [<a href="https://pubmed.ncbi.nlm.nih.gov/27731973" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioconjug.+Chem.&amp;title=Ultrasmall+gold+nanoparticles+behavior+in+vivo+modulated+by+surface+polyethylene+glycol+(PEG)+grafting&amp;volume=28&amp;publication_year=2017&amp;pages=239-243&amp;pmid=27731973&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r52">52. <span class="mixed-citation">Huang Y., Yu M., Zheng J., <span class="ref-title">Proximal tubules eliminate endocytosed gold nanoparticles through an organelle-extrusion-mediated self-renewal mechanism</span>. <span class="ref-journal">Nat. Nanotechnol.</span>
<span class="ref-vol"><strong>18</strong></span>, 637&#x02013;646 (2023). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10917148/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37069289" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Nanotechnol.&amp;title=Proximal+tubules+eliminate+endocytosed+gold+nanoparticles+through+an+organelle-extrusion-mediated+self-renewal+mechanism&amp;volume=18&amp;publication_year=2023&amp;pages=637-646&amp;pmid=37069289&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r53">53. <span class="mixed-citation">Chen C., et al., <span class="ref-title">Structural basis for molecular recognition of folic acid by folate receptors</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol"><strong>500</strong></span>, 486&#x02013;489 (2013). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5797940/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23851396" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structural+basis+for+molecular+recognition+of+folic+acid+by+folate+receptors&amp;volume=500&amp;publication_year=2013&amp;pages=486-489&amp;pmid=23851396&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r54">54. <span class="mixed-citation">Zhao R., et al., <span class="ref-title">A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis</span>. <span class="ref-journal">J. Biol. Chem.</span>
<span class="ref-vol"><strong>284</strong></span>, 4267&#x02013;4274 (2009). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2640977/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19074442" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=A+role+for+the+proton-coupled+folate+transporter+(PCFT-SLC46A1)+in+folate+receptor-mediated+endocytosis&amp;volume=284&amp;publication_year=2009&amp;pages=4267-4274&amp;pmid=19074442&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r55">55. <span class="mixed-citation">Nawaz F. Z., Kipreos E. T., <span class="ref-title">Emerging roles for folate receptor FOLR1 in signaling and cancer</span>. <span class="ref-journal">Trends Endocrinol. Metab.</span>
<span class="ref-vol"><strong>33</strong></span>, 159&#x02013;174 (2022). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8923831/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35094917" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Endocrinol.+Metab.&amp;title=Emerging+roles+for+folate+receptor+FOLR1+in+signaling+and+cancer&amp;volume=33&amp;publication_year=2022&amp;pages=159-174&amp;pmid=35094917&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r56">56. <span class="mixed-citation">Kuo C. T., Sen Lee W., <span class="ref-title">Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines</span>. <span class="ref-journal">Cancer Lett.</span>
<span class="ref-vol"><strong>378</strong></span>, 104&#x02013;110 (2016). [<a href="https://pubmed.ncbi.nlm.nih.gov/27233474" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett.&amp;title=Progesterone+receptor+activation+is+required+for+folic+acid-induced+anti-proliferation+in+colorectal+cancer+cell+lines&amp;volume=378&amp;publication_year=2016&amp;pages=104-110&amp;pmid=27233474&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r57">57. <span class="mixed-citation">Hansen M. F., et al., <span class="ref-title">Folic acid mediates activation of the pro-oncogene STAT3 via the folate receptor alpha</span>. <span class="ref-journal">Cell. Signal.</span>
<span class="ref-vol"><strong>27</strong></span>, 1356&#x02013;1368 (2015). [<a href="https://pubmed.ncbi.nlm.nih.gov/25841994" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell.+Signal.&amp;title=Folic+acid+mediates+activation+of+the+pro-oncogene+STAT3+via+the+folate+receptor+alpha&amp;volume=27&amp;publication_year=2015&amp;pages=1356-1368&amp;pmid=25841994&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r58">58. <span class="mixed-citation">Liz-Marz&#x000e1;n L. M., et al., <span class="ref-title">What do we mean when we say nanomedicine?</span>
<span class="ref-journal">ACS Nano</span>
<span class="ref-vol"><strong>16</strong></span>, 13257&#x02013;13259 (2022). <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Nano&amp;title=What+do+we+mean+when+we+say+nanomedicine?&amp;volume=16&amp;publication_year=2022&amp;pages=13257-13259&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r59">59. <span class="mixed-citation">Tsoi K. M., et al., <span class="ref-title">Mechanism of hard-nanomaterial clearance by the liver</span>. <span class="ref-journal">Nat. Mater.</span>
<span class="ref-vol"><strong>15</strong></span>, 1212&#x02013;1221 (2016). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5132626/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27525571" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Mater.&amp;title=Mechanism+of+hard-nanomaterial+clearance+by+the+liver&amp;volume=15&amp;publication_year=2016&amp;pages=1212-1221&amp;pmid=27525571&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r60">60. <span class="mixed-citation">Arvizo R. R., et al., <span class="ref-title">Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A.</span>
<span class="ref-vol"><strong>110</strong></span>, 6700&#x02013;6705 (2013). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3637766/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23569259" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=Inhibition+of+tumor+growth+and+metastasis+by+a+self-therapeutic+nanoparticle&amp;volume=110&amp;publication_year=2013&amp;pages=6700-6705&amp;pmid=23569259&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r61">61. <span class="mixed-citation">Han R., et al., <span class="ref-title">Alkyl-terminated gold nanoparticles as a self-therapeutic treatment for psoriasis</span>. <span class="ref-journal">Nano Lett.</span>
<span class="ref-vol"><strong>21</strong></span>, 8723&#x02013;8733 (2021). [<a href="https://pubmed.ncbi.nlm.nih.gov/34618470" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nano+Lett.&amp;title=Alkyl-terminated+gold+nanoparticles+as+a+self-therapeutic+treatment+for+psoriasis&amp;volume=21&amp;publication_year=2021&amp;pages=8723-8733&amp;pmid=34618470&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r62">62. <span class="mixed-citation">Mart&#x000ed;nez-Klimova E., Aparicio-Trejo O. E., Tapia E., Pedraza-Chaverri J., <span class="ref-title">Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments</span>. <span class="ref-journal">Biomolecules</span>
<span class="ref-vol"><strong>9</strong></span>, 141 (2019). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6523883/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30965656" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=Unilateral+ureteral+obstruction+as+a+model+to+investigate+fibrosis-attenuating+treatments&amp;volume=9&amp;publication_year=2019&amp;pages=141&amp;pmid=30965656&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r63">63. <span class="mixed-citation">Huang H., et al., <span class="ref-title">Farnesylthiosalicylic acid-loaded albumin nanoparticle alleviates renal fibrosis by inhibiting Ras/Raf1/p38 signaling pathway</span>. <span class="ref-journal">Int. J. Nanomedicine</span>
<span class="ref-vol"><strong>16</strong></span>, 6441&#x02013;6453 (2021). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8464329/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34584410" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Nanomedicine&amp;title=Farnesylthiosalicylic+acid-loaded+albumin+nanoparticle+alleviates+renal+fibrosis+by+inhibiting+Ras/Raf1/p38+signaling+pathway&amp;volume=16&amp;publication_year=2021&amp;pages=6441-6453&amp;pmid=34584410&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r64">64. <span class="mixed-citation">Balfourier A., et al., <span class="ref-title">Gold-based therapy: From past to present</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A.</span>
<span class="ref-vol"><strong>117</strong></span>, 22639&#x02013;22648 (2020). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7502769/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32900936" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=Gold-based+therapy:+From+past+to+present&amp;volume=117&amp;publication_year=2020&amp;pages=22639-22648&amp;pmid=32900936&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r65">65. <span class="mixed-citation">Kumthekar P., et al., <span class="ref-title">A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma</span>. <span class="ref-journal">Sci. Transl. Med.</span>
<span class="ref-vol"><strong>13</strong></span>, 3945 (2021). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8272521/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33692132" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Transl.+Med.&amp;title=A+first-in-human+phase+0+clinical+study+of+RNA+interference-based+spherical+nucleic+acids+in+patients+with+recurrent+glioblastoma&amp;volume=13&amp;publication_year=2021&amp;pages=3945&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r66">66. <span class="mixed-citation">Falagan-Lotsch P., Grzincic E. M., Murphy C. J., <span class="ref-title">One low-dose exposure of gold nanoparticles induces long-term changes in human cells</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A.</span>
<span class="ref-vol"><strong>113</strong></span>, 13318&#x02013;13323 (2016). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5127334/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27821760" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=One+low-dose+exposure+of+gold+nanoparticles+induces+long-term+changes+in+human+cells&amp;volume=113&amp;publication_year=2016&amp;pages=13318-13323&amp;pmid=27821760&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r67">67. <span class="mixed-citation">Balfourier A., et al., <span class="ref-title">Unexpected intracellular biodegradation and recrystallization of gold nanoparticles</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A.</span>
<span class="ref-vol"><strong>117</strong></span>, 103&#x02013;113 (2020). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6955300/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31852822" ref="reftype=pubmed&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=Unexpected+intracellular+biodegradation+and+recrystallization+of+gold+nanoparticles&amp;volume=117&amp;publication_year=2020&amp;pages=103-113&amp;pmid=31852822&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r68">68. <span class="mixed-citation">Dunnett C. W., <span class="ref-title">A multiple comparison procedure for comparing several treatments with a control</span>. <span class="ref-journal">J. Am. Stat. Assoc.</span>
<span class="ref-vol"><strong>50</strong></span>, 1096&#x02013;1121 (1955). <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Stat.+Assoc.&amp;title=A+multiple+comparison+procedure+for+comparing+several+treatments+with+a+control&amp;volume=50&amp;publication_year=1955&amp;pages=1096-1121&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10589645&amp;issue-id=447702&amp;journal-id=2&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Proceedings of the National Academy of Sciences of the United States of America</span> are provided here courtesy of <strong>National Academy of Sciences</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10589645/pdf/pnas.202305662.pdf" class="int-view">PDF (27M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10589645/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10589645/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10589645" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10589645%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="oLdw2BBbC92e3kvJvOoHjoDw9x7tDPA3WSJQ3xdNdpSLaVGKteGc8SJUxEyU85NW">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10589645%2F&amp;text=A%20sub-10-nm%2C%20folic%20acid-conjugated%20gold%20nanoparticle%20as%20self-therapeutic%20treatment%20of%20tubulointerstitial%20fibrosis%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10589645%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589645/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10589645/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37812696/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10589645/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37812696/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10589645/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10589645/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10589645/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
